{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:31:52Z","timestamp":1786512712484,"version":"build-2736575974"},"reference-count":341,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Multiple Sclerosis (MS), the most common demyelinating disease of the Central Nervous\nSystem (CNS), is characterized in its pathogenesis by an interplay of mechanisms pertaining to aberrant\nimmune response, acute and chronic inflammation, glial housekeeping, and neuron survival, ultimately\nresulting in demyelination, synaptic dysfunction, and neuroaxonal loss. Experimental models\nas well as epidemiological observations support the hypothesis of a role of diet in the disease onset,\nactivity, and progression. It has been suggested that Western-type diets might be detrimental,\nwhile on the other hand, certain dietary regimens, like Mediterranean, low-fat, ketogenic, or intermittent\nfasting, might lead to disease amelioration, possibly through differential regulatory effects upon\ninflammation, immunity, and regenerative processes of neurons and glia. Under this perspective,\nimmunometabolites, small intermediates including among the others citrate, itaconate, lactate, glutamate,\nglutamine, alfa-ketoglutarate, 2-hydroxyglutarate, fumarate, ceramides, whose turn-over reflects\nmetabolic reprogramming of immune cells, might be viewed as significant regulators of cellular\nresponses against either local or systemic noxious stimuli, both in the periphery and in the CNS.\nThe present narrative review aims at summarizing current experimental and clinical evidence regarding\nthe role of immunometabolites in shaping MS pathology, to address whether they could be relevant\neither as disease markers or therapeutic targets, and whether they might be differentially influenced\nby dietary approaches, especially by Mediterranean Pattern Diets (MPD).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/011570159x382929250719084728","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:23:28Z","timestamp":1754889808000},"page":"956-987","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mediterranean Pattern Diet in Multiple Sclerosis: A Review Focusing on Immunometabolites"],"prefix":"10.2174","volume":"24","author":[{"given":"Giulio","family":"Papiri","sequence":"first","affiliation":[{"name":"Neurology Unit, Ospedale Provinciale &#34;Madonna del Soccorso&#34;, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Paci","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale Provinciale &#34;Madonna del Soccorso&#34;, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"D'andreamatteo","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale Provinciale &#34;Madonna del Soccorso&#34;, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Membrino","sequence":"additional","affiliation":[{"name":"Departmentof Clinical Sciences, Section of Biochemistry, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60100,Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Di Crescenzo","sequence":"additional","affiliation":[{"name":"Departmentof Clinical Sciences, Section of Biochemistry, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60100,Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Cacchio","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale Provinciale &#34;Madonna del Soccorso&#34;, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cagnetti","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale Provinciale &#34;Madonna del Soccorso&#34;, 63074 San Benedetto del Tronto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Vignini","sequence":"additional","affiliation":[{"name":"Departmentof Clinical Sciences, Section of Biochemistry, Biology and Physics, Universit\u00e0 Politecnica delle Marche, 60100,Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3399\/bjgp14X682609","volume":"64","author":"Dimitrov L.G.","year":"2014","unstructured":"Dimitrov L.G.; Turner B.; What\u2019s new in multiple sclerosis? Br J Gen Pract  2014,64(629),612-613","journal-title":"Br J Gen Pract"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1212\/WNL.41.5.685","volume":"41","author":"Rao S.M.","year":"1991","unstructured":"Rao S.M.; Leo G.J.; Bernardin L.; Unverzagt F.; Cognitive dysfunction in multiple sclerosis. Neurology  1991,41(5),685-691","journal-title":"Neurology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1177\/13524585211046739","volume":"28","author":"Grothe M.","year":"2022","unstructured":"Grothe M.; Ellenberger D.; von Podewils F.; Stahmann A.; Rommer P.S.; Zettl U.K.; Epilepsy as a predictor of disease progression in multiple sclerosis. Mult Scler  2022,28(6),942-949","journal-title":"Mult Scler"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"Thompson A.J.","year":"2018","unstructured":"Thompson A.J.; Banwell B.L.; Barkhof F.; Carroll W.M.; Coetzee T.; Comi G.; Correale J.; Fazekas F.; Filippi M.; Freedman M.S.; Fujihara K.; Galetta S.L.; Hartung H.P.; Kappos L.; Lublin F.D.; Marrie R.A.; Miller A.E.; Miller D.H.; Montalban X.; Mowry E.M.; Sorensen P.S.; Tintor\u00e9 M.; Traboulsee A.L.; Trojano M.; Uitdehaag B.M.J.; Vukusic S.; Waubant E.; Weinshenker B.G.; Reingold S.C.; Cohen J.A.; Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol  2018,17(2),162-173","journal-title":"Lancet Neurol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"Dobson R.","year":"2019","unstructured":"Dobson R.; Giovannoni G.; Multiple sclerosis \u2013 a review. Eur J Neurol  2019,26(1),27-40","journal-title":"Eur J Neurol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neurol.2015.10.006","volume":"172","author":"Leray E.","year":"2016","unstructured":"Leray E.; Moreau T.; Fromont A.; Edan G.; Epidemiology of multiple sclerosis. Rev Neurol  2016,172(1),3-13","journal-title":"Rev Neurol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"Olsson T.","year":"2017","unstructured":"Olsson T.; Barcellos L.F.; Alfredsson L.; Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol  2017,13(1),25-36","journal-title":"Nat Rev Neurol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/s41467-018-04732-5","volume":"9","author":"Kular L.","year":"2018","unstructured":"Kular L.; Liu Y.; Ruhrmann S.; Zheleznyakova G.; Marabita F.; Gomez-Cabrero D.; James T.; Ewing E.; Lind\u00e9n M.; G\u00f3rnikiewicz B.; Aeinehband S.; Stridh P.; Link J.; Andlauer T.F.M.; Gasperi C.; Wiendl H.; Zipp F.; Gold R.; Tackenberg B.; Weber F.; Hemmer B.; Strauch K.; Heilmann-Heimbach S.; Rawal R.; Schminke U.; Schmidt C.O.; Kacprowski T.; Franke A.; Laudes M.; Dilthey A.T.; Celius E.G.; S\u00f8ndergaard H.B.; Tegn\u00e9r J.; Harbo H.F.; Oturai A.B.; Olafsson S.; Eggertsson H.P.; Halldorsson B.V.; Hjaltason H.; Olafsson E.; Jonsdottir I.; Stefansson K.; Olsson T.; Piehl F.; Ekstr\u00f6m T.J.; Kockum I.; Feinberg A.P.; Jagodic M.; DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis. Nat Commun  2018,9(1),2397","journal-title":"Nat Commun"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"Baecher-Allan C.","year":"2018","unstructured":"Baecher-Allan C.; Kaskow B.J.; Weiner H.L.; Multiple sclerosis: Mechanisms and immunotherapy. Neuron  2018,97(4),742-768","journal-title":"Neuron"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1179\/1743132812Y.0000000072","volume":"34","author":"Minagar A.","year":"2012","unstructured":"Minagar A.; Maghzi A.H.; McGee J.C.; Alexander J.S.; Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy. Neurol Res  2012,34(8),738-745","journal-title":"Neurol Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","volume":"30","author":"Van San E.","year":"2023","unstructured":"Van San E.; Debruyne A.C.; Veeckmans G.; Tyurina Y.Y.; Tyurin V.A.; Zheng H.; Choi S.M.; Augustyns K.; van Loo G.; Michalke B.; Venkataramani V.; Toyokuni S.; Bayir H.; Vandenabeele P.; Hassannia B.; Vanden Berghe T.; Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death Differ  2023,30(9),2092-2103","journal-title":"Cell Death Differ"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1177\/13524585231204122","volume":"29","author":"Zhang Y.","year":"2023","unstructured":"Zhang Y.; Atkinson J.; Burd C.E.; Graves J.; Segal B.M.; Biological aging in multiple sclerosis. Mult Scler  2023,29(14),1701-1708","journal-title":"Mult Scler"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s13668-018-0236-z","volume":"7","author":"Katz S.I.","year":"2018","unstructured":"Katz S.I.; The role of diet in multiple sclerosis: Mechanistic connections and current evidence. Curr Nutr Rep  2018,7(3),150-160","journal-title":"Curr Nutr Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nbd.2007.03.012","volume":"27","author":"Centonze D.","year":"2007","unstructured":"Centonze D.; Rossi S.; Tortiglione A.; Picconi B.; Prosperetti C.; De Chiara V.; Bernardi G.; Calabresi P.; Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery. Neurobiol Dis  2007,27(1),44-53","journal-title":"Neurobiol Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","volume":"21","author":"Bierhansl L.","year":"2022","unstructured":"Bierhansl L.; Hartung H.P.; Aktas O.; Ruck T.; Roden M.; Meuth S.G.; Thinking outside the box: Non-canonical targets in multiple sclerosis. Nat Rev Drug Discov  2022,21(8),578-600","journal-title":"Nat Rev Drug Discov"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","volume":"183","author":"J\u00e4ger A.","year":"2009","unstructured":"J\u00e4ger A.; Dardalhon V.; Sobel R.A.; Bettelli E.; Kuchroo V.K.; Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol  2009,183(11),7169-7177","journal-title":"J Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","volume":"17","author":"Rodr\u00edguez M.S.","year":"2022","unstructured":"Rodr\u00edguez M.S.; Farez M.F.; Quintana F.J.; The immune response in multiple sclerosis. Annu Rev Pathol  2022,17(1),121-139","journal-title":"Annu Rev Pathol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/400_2009_11","volume":"51","author":"Sakuishi K.","year":"2009","unstructured":"Sakuishi K.; Miyake S.; Yamamura T.; Role of NK cells and invariant NKT cells in multiple sclerosis. Results Probl Cell Differ  2009,51,127-147","journal-title":"Results Probl Cell Differ"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/nu15040942","volume":"15","author":"Altieri C.","year":"2023","unstructured":"Altieri C.; Speranza B.; Corbo M.R.; Sinigaglia M.; Bevilacqua A.; Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives. Nutrients  2023,15(4),942","journal-title":"Nutrients"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"912828","DOI":"10.3389\/fneur.2022.912828","volume":"13","author":"Vestergaard M.B.","year":"2022","unstructured":"Vestergaard M.B.; Frederiksen J.L.; Larsson H.B.W.; Cramer S.P.; Cerebrovascular reactivity and neurovascular coupling in multiple sclerosis-a systematic review. Front Neurol  2022,13,912828","journal-title":"Front Neurol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2019.05.011","volume":"669","author":"Butturini E.","year":"2019","unstructured":"Butturini E.; Boriero D.; Carcereri de Prati A.; Mariotto S.; STAT1 drives M1 microglia activation and neuroinflammation under hypoxia. Arch Biochem Biophys  2019,669,22-30","journal-title":"Arch Biochem Biophys"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"105172","DOI":"10.1016\/j.nbd.2020.105172","volume":"148","author":"Bennett M.L.","year":"2021","unstructured":"Bennett M.L.; Viaene A.N.; What are activated and reactive glia and what is their role in neurodegeneration? Neurobiol Dis  2021,148,105172","journal-title":"Neurobiol Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/cells8121508","volume":"8","author":"Piatek P.","year":"2019","unstructured":"Piatek P.; Namiecinska M.; Domowicz M.; Przygodzka P.; Wieczorek M.; Michlewska S.; Lewkowicz N.; Tarkowski M.; Lewkowicz P.M.S.; CD49d+CD154+ lymphocytes reprogram oligodendrocytes into immune reactive cells affecting CNS regeneration. Cells  2019,8(12),1508","journal-title":"Cells"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"Liddelow S.A.","year":"2017","unstructured":"Liddelow S.A.; Guttenplan K.A.; Clarke L.E.; Bennett F.C.; Bohlen C.J.; Schirmer L.; Bennett M.L.; M\u00fcnch A.E.; Chung W.S.; Peterson T.C.; Wilton D.K.; Frouin A.; Napier B.A.; Panicker N.; Kumar M.; Buckwalter M.S.; Rowitch D.H.; Dawson V.L.; Dawson T.M.; Stevens B.; Barres B.A.; Neurotoxic reactive astrocytes are induced by activated microglia. Nature  2017,541(7638),481-487","journal-title":"Nature"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/biology8020037","volume":"8","author":"Barcelos I.P.d.","year":"2019","unstructured":"Barcelos I.P.d.; Troxell R.M.; Graves J.S.; Mitochondrial dysfunction and multiple sclerosis. Biology  2019,8(2),37","journal-title":"Biology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"17562864211066751","DOI":"10.1177\/17562864211066751","volume":"15","author":"Giovannoni G.","year":"2022","unstructured":"Giovannoni G.; Popescu V.; Wuerfel J.; Hellwig K.; Iacobaeus E.; Jensen M.B.; Garc\u00eda-Dom\u00ednguez J.M.; Sousa L.; De Rossi N.; Hupperts R.; Fenu G.; Bodini B.; Kuusisto H.M.; Stankoff B.; Lycke J.; Airas L.; Granziera C.; Scalfari A.; Smouldering multiple sclerosis: The \u2018real MS\u2019. Ther Adv Neurol Disord  2022,15,17562864211066751","journal-title":"Ther Adv Neurol Disord"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ana.1255","volume":"50","author":"Prineas J.W.","year":"2001","unstructured":"Prineas J.W.; Kwon E.E.; Cho E.S.; Sharer L.R.; Barnett M.H.; Oleszak E.L.; Hoffman B.; Morgan B.P.; Immunopathology of secondary\u2010progressive multiple sclerosis. Ann Neurol  2001,50(5),646-657","journal-title":"Ann Neurol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.nic.2008.06.005","volume":"18","author":"Lassmann H.","year":"2008","unstructured":"Lassmann H.; The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am  2008,18(4),563-576","journal-title":"Neuroimaging Clin N Am"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/glia.23913","volume":"69","author":"York E.M.","year":"2021","unstructured":"York E.M.; Zhang J.; Choi H.B.; MacVicar B.A.; Neuroinflammatory inhibition of synaptic long\u2010term potentiation requires immunometabolic reprogramming of microglia. Glia  2021,69(3),567-578","journal-title":"Glia"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","volume":"9","author":"Ponath G.","year":"2018","unstructured":"Ponath G.; Park C.; Pitt D.; The role of astrocytes in multiple sclerosis. Front Immunol  2018,9,217","journal-title":"Front Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/brain\/aws262","volume":"136","author":"Skripuletz T.","year":"2013","unstructured":"Skripuletz T.; Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Brain  2013,136(Pt 1),147-167","journal-title":"Brain"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","volume":"45","author":"Jin Z.","year":"2013","unstructured":"Jin Z.; Mendu S.K.; Birnir B.; GABA is an effective immunomodulatory molecule. Amino Acids  2013,45(1),87-94","journal-title":"Amino Acids"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.4049\/jimmunol.170.8.4362","volume":"170","author":"Ganor Y.","year":"2003","unstructured":"Ganor Y.; Besser M.; Ben-Zakay N.; Unger T.; Levite M.; Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol  2003,170(8),4362-4372","journal-title":"J Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-016-1661-z","volume":"124","author":"Levite M.","year":"2017","unstructured":"Levite M.; Glutamate, T cells and multiple sclerosis. J Neural Transm  2017,124(7),775-798","journal-title":"J Neural Transm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3390\/ijms21051663","volume":"21","author":"Enders M.","year":"2020","unstructured":"Enders M.; Heider T.; Ludwig A.; Kuerten S.; Strategies for neuroprotection in multiple sclerosis and the role of calcium. Int J Mol Sci  2020,21(5),1663","journal-title":"Int J Mol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/brain\/awv353","volume":"139","author":"J\u00fcrgens T.","year":"2016","unstructured":"J\u00fcrgens T.; Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. Brain  2016,139(Pt 1),39-46","journal-title":"Brain"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"0303211","DOI":"10.1371\/journal.pone.0303211","volume":"19","author":"Baldasso B.D.","year":"2024","unstructured":"Baldasso B.D.; Raza S.Z.; Islam S.S.; Burry I.B.; Newell C.J.; Hillier S.R.; Ploughman M.; Disrupted hemodynamic response within dorsolateral prefrontal cortex during cognitive tasks among people with multiple sclerosis-related fatigue. PLoS One  2024,19(6),0303211","journal-title":"PLoS One"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.27165","volume":"97","author":"Brier M.R.","year":"2025","unstructured":"Brier M.R.; Judge B.; Ying C.; Salter A.; An H.; Increased white matter aerobic glycolysis in multiple sclerosis. Ann Neurol  2025,97(4),766-778","journal-title":"Ann Neurol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fphys.2018.00855","volume":"9","author":"Patern\u00f2 R.","year":"2018","unstructured":"Patern\u00f2 R.; Chillon J.M.; Potentially common therapeutic targets for multiple sclerosis and ischemic stroke. Front Physiol  2018,9,855","journal-title":"Front Physiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","volume":"1802","author":"Mao P.","year":"2010","unstructured":"Mao P.; Reddy P.H.; Is multiple sclerosis a mitochondrial disease? Biochim Biophys Acta Mol Basis Dis  2010,1802(1),66-79","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cen3.12349","volume":"8","author":"Nakahara J.","year":"2017","unstructured":"Nakahara J.; Remyelination in multiple sclerosis: Pathology and treatment strategies. Clin Exp Neuroimmunol  2017,8(S1),40-46","journal-title":"Clin Exp Neuroimmunol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0140-6736(16)30169-6","volume":"388","author":"Atkins H.L.","year":"2016","unstructured":"Atkins H.L.; Bowman M.; Allan D.; Anstee G.; Arnold D.L.; Bar-Or A.; Bence-Bruckler I.; Birch P.; Bredeson C.; Chen J.; Fergusson D.; Halpenny M.; Hamelin L.; Huebsch L.; Hutton B.; Laneuville P.; Lapierre Y.; Lee H.; Martin L.; McDiarmid S.; O\u2019Connor P.; Ramsay T.; Sabloff M.; Walker L.; Freedman M.S.; Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: A multicentre single-group phase 2 trial. Lancet  2016,388(10044),576-585","journal-title":"Lancet"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"Lassmann H.","year":"2018","unstructured":"Lassmann H.; Multiple sclerosis pathology. Cold Spring Harb Perspect Med  2018,8(3),a028936","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","volume":"21","author":"Wang P.F.","year":"2024","unstructured":"Wang P.F.; Jiang F.; Zeng Q.M.; Yin W.F.; Hu Y.Z.; Li Q.; Hu Z.L.; Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. J Neuroinflammation  2024,21(1),28","journal-title":"J Neuroinflammation"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0302-7","volume":"51","author":"Lee I.H.","year":"2019","unstructured":"Lee I.H.; Mechanisms and disease implications of sirtuin-mediated autophagic regulation. Exp Mol Med  2019,51(9),1-11","journal-title":"Exp Mol Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.3390\/ijms20204975","volume":"20","author":"Ng X.","year":"2019","unstructured":"Ng X.; Sadeghian M.; Heales S.; Hargreaves I.P.; Assessment of mitochondrial dysfunction in experimental autoimmune encephalomyelitis (eae) models of multiple sclerosis. Int J Mol Sci  2019,20(20),4975","journal-title":"Int J Mol Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"33249","DOI":"10.1038\/srep33249","volume":"6","author":"Sadeghian M.","year":"2016","unstructured":"Sadeghian M.; Mastrolia V.; Rezaei Haddad A.; Mosley A.; Mullali G.; Schiza D.; Sajic M.; Hargreaves I.; Heales S.; Duchen M.R.; Smith K.J.; Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep  2016,6(1),33249","journal-title":"Sci Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.molmet.2022.101468","volume":"60","author":"Riechers S.P.","year":"2022","unstructured":"Riechers S.P.; Mojsilovic-Petrovic J.; Belton T.B.; Chakrabarty R.P.; Garjani M.; Medvedeva V.; Dalton C.; Wong Y.C.; Chandel N.S.; Dienel G.; Kalb R.G.; Neurons undergo pathogenic metabolic reprogramming in models of familial ALS. Mol Metab  2022,60,101468","journal-title":"Mol Metab"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ana.20736","volume":"59","author":"Dutta R.","year":"2006","unstructured":"Dutta R.; McDonough J.; Yin X.; Peterson J.; Chang A.; Torres T.; Gudz T.; Macklin W.B.; Lewis D.A.; Fox R.J.; Rudick R.; Mirnics K.; Trapp B.D.; Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol  2006,59(3),478-489","journal-title":"Ann Neurol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"102025","DOI":"10.1016\/j.msard.2020.102025","volume":"41","author":"Armon-Omer A.","year":"2020","unstructured":"Armon-Omer A.; Neuman H.; Sharabi-Nov A.; Shahien R.; Mitochondrial activity is impaired in lymphocytes of MS patients in correlation with disease severity. Mult Scler Relat Disord  2020,41,102025","journal-title":"Mult Scler Relat Disord"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"200312","DOI":"10.1212\/NXI.0000000000200312","volume":"11","author":"Fransson J.","year":"2024","unstructured":"Fransson J.; Bachelin C.; Ichou F.; Guillot-No\u00ebl L.; Ponnaiah M.; Gloaguen A.; Maillart E.; Stankoff B.; Tenenhaus A.; Fontaine B.; Mochel F.; Louapre C.; Zujovic V.; Multiple sclerosis patient macrophages impaired metabolism leads to an altered response to activation stimuli. Neurol Neuroimmunol Neuroinflamm  2024,11(6),200312","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","volume":"34","author":"Yoshida G.J.","year":"2015","unstructured":"Yoshida G.J.; Metabolic reprogramming: The emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res  2015,34(1),111","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.3390\/ijms24065493","volume":"24","author":"Pang Y.","year":"2023","unstructured":"Pang Y.; Lu T.; Xu-Monette Z.Y.; Young K.H.; Metabolic reprogramming and potential therapeutic targets in lymphoma. Int J Mol Sci  2023,24(6),5493","journal-title":"Int J Mol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41586-024-07187-5","volume":"627","author":"Lee H.G.","year":"2024","unstructured":"Lee H.G.; Rone J.M.; Li Z.; Akl C.F.; Shin S.W.; Lee J.H.; Flausino L.E.; Pernin F.; Chao C.C.; Kleemann K.L.; Srun L.; Illouz T.; Giovannoni F.; Charabati M.; Sanmarco L.M.; Kenison J.E.; Piester G.; Zandee S.E.J.; Antel J.P.; Rothhammer V.; Wheeler M.A.; Prat A.; Clark I.C.; Quintana F.J.; Disease-associated astrocyte epigenetic memory promotes CNS pathology. Nature  2024,627(8005),865-872","journal-title":"Nature"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1159\/000535452","volume":"15","author":"Ryan D.G.","year":"2023","unstructured":"Ryan D.G.; Peace C.G.; Hooftman A.; Basic mechanisms of immunometabolites in shaping the immune response. J Innate Immun  2023,15(1),925-943","journal-title":"J Innate Immun"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1113\/JP278810","volume":"599","author":"Vaupel P.","year":"2021","unstructured":"Vaupel P.; Multhoff G.; Revisiting the Warburg effect: Historical dogma versus current understanding. J Physiol  2021,599(6),1745-1757","journal-title":"J Physiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molimm.2015.07.034","volume":"68","author":"Donnelly R.P.","year":"2015","unstructured":"Donnelly R.P.; Finlay D.K.; Glucose, glycolysis and lymphocyte responses. Mol Immunol  2015,68(2 Pt C),513-519","journal-title":"Mol Immunol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fimmu.2019.00115","volume":"10","author":"Cluxton D.","year":"2019","unstructured":"Cluxton D.; Petrasca A.; Moran B.; Fletcher J.M.; Differential regulation of human treg and th17 cells by fatty acid synthesis and glycolysis. Front Immunol  2019,10,115","journal-title":"Front Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3389\/fimmu.2019.02993","volume":"10","author":"Batista-Gonzalez A.","year":"2020","unstructured":"Batista-Gonzalez A.; Vidal R.; Criollo A.; Carre\u00f1o L.J.; New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. Front Immunol  2020,10,2993","journal-title":"Front Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"Vander Heiden M.G.","year":"2009","unstructured":"Vander Heiden M.G.; Cantley L.C.; Thompson C.B.; Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science  2009,324(5930),1029-1033","journal-title":"Science"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"eaaz6314","DOI":"10.1126\/scitranslmed.aaz6314","volume":"13","author":"Liu X.","year":"2021","unstructured":"Liu X.; Hartman C.L.; Li L.; Albert C.J.; Si F.; Gao A.; Huang L.; Zhao Y.; Lin W.; Hsueh E.C.; Shen L.; Shao Q.; Hoft D.F.; Ford D.A.; Peng G.; Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci Transl Med  2021,13(587),eaaz6314","journal-title":"Sci Transl Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"Mitroulis I.","year":"2018","unstructured":"Mitroulis I.; Ruppova K.; Wang B.; Chen L.S.; Grzybek M.; Grinenko T.; Eugster A.; Troullinaki M.; Palladini A.; Kourtzelis I.; Chatzigeorgiou A.; Schlitzer A.; Beyer M.; Joosten L.A.B.; Isermann B.; Lesche M.; Petzold A.; Simons K.; Henry I.; Dahl A.; Schultze J.L.; Wielockx B.; Zamboni N.; Mirtschink P.; Coskun \u00dc.; Hajishengallis G.; Netea M.G.; Chavakis T.; Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell  2018,172(1-2),147-161.e12","journal-title":"Cell"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","volume":"9","author":"Williams N.C.","year":"2018","unstructured":"Williams N.C.; O\u2019Neill L.A.J.; A role for the Krebs cycle intermediate citrate in metabolic reprogramming in innate immunity and inflammation. Front Immunol  2018,9,141","journal-title":"Front Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"Mossmann D.","year":"2018","unstructured":"Mossmann D.; Park S.; Hall M.N.; mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer  2018,18(12),744-757","journal-title":"Nat Rev Cancer"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1478-811X-11-42","volume":"11","author":"Cavadas M.A.S.","year":"2013","unstructured":"Cavadas M.A.S.; Nguyen L.K.; Cheong A.; Hypoxia-inducible factor (HIF) network: Insights from mathematical models. Cell Commun Signal  2013,11(1),42","journal-title":"Cell Commun Signal"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1042\/CS20201394","volume":"135","author":"Cardoso D.","year":"2021","unstructured":"Cardoso D.; Perucha E.; Cholesterol metabolism: A new molecular switch to control inflammation. Clin Sci  2021,135(11),1389-1408","journal-title":"Clin Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijbiomac.2021.12.009","volume":"195","author":"Grao-Cruces E.","year":"2022","unstructured":"Grao-Cruces E.; Lopez-Enriquez S.; Martin M.E.; Montserrat-de la Paz S.; High-density lipoproteins and immune response: A review. Int J Biol Macromol  2022,195,117-123","journal-title":"Int J Biol Macromol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/ijms19113447","volume":"19","author":"Cheng C.F.","year":"2018","unstructured":"Cheng C.F.; Ku H.C.; Lin H.; PGC-1\u03b1 as a pivotal factor in lipid and metabolic regulation. Int J Mol Sci  2018,19(11),3447","journal-title":"Int J Mol Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"13683","DOI":"10.1038\/ncomms13683","volume":"7","author":"Angela M.","year":"2016","unstructured":"Angela M.; Endo Y.; Asou H.K.; Yamamoto T.; Tumes D.J.; Tokuyama H.; Yokote K.; Nakayama T.; Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR\u03b3 directs early activation of T cells. Nat Commun  2016,7(1),13683","journal-title":"Nat Commun"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/s41467-023-42170-0","volume":"14","author":"Jeong D.W.","year":"2023","unstructured":"Jeong D.W.; Park J.W.; Kim K.S.; Kim J.; Huh J.; Seo J.; Kim Y.L.; Cho J.Y.; Lee K.W.; Fukuda J.; Chun Y.S.; Palmitoylation-driven PHF2 ubiquitination remodels lipid metabolism through the SREBP1c axis in hepatocellular carcinoma. Nat Commun  2023,14(1),6370","journal-title":"Nat Commun"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"600368","DOI":"10.3389\/fcell.2020.600368","volume":"8","author":"Yang X.","year":"2020","unstructured":"Yang X.; Chatterjee V.; Ma Y.; Zheng E.; Yuan S.Y.; Protein palmitoylation in leukocyte signaling and function. Front Cell Dev Biol  2020,8,600368","journal-title":"Front Cell Dev Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41423-022-00902-0","volume":"19","author":"Morris G.","year":"2022","unstructured":"Morris G.; Gevezova M.; Sarafian V.; Maes M.; Redox regulation of the immune response. Cell Mol Immunol  2022,19(10),1079-1101","journal-title":"Cell Mol Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.it.2022.10.003","volume":"43","author":"Olona A.","year":"2022","unstructured":"Olona A.; Leishman S.; Anand P.K.; The NLRP3 inflammasome: Regulation by metabolic signals. Trends Immunol  2022,43(12),978-989","journal-title":"Trends Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41467-023-36594-x","volume":"14","author":"Aso K.","year":"2023","unstructured":"Aso K.; Kono M.; Kanda M.; Kudo Y.; Sakiyama K.; Hisada R.; Karino K.; Ueda Y.; Nakazawa D.; Fujieda Y.; Kato M.; Amengual O.; Atsumi T.; Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nat Commun  2023,14(1),984","journal-title":"Nat Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/brain\/awy344","volume":"142","author":"Ntranos A.","year":"2019","unstructured":"Ntranos A.; Ntranos V.; Bonnefil V.; Liu J.; Kim-Schulze S.; He Y.; Zhu Y.; Brandstadter R.; Watson C.T.; Sharp A.J.; Katz S.I.; Casaccia P.; Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis. Brain  2019,142(3),647-661","journal-title":"Brain"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","volume":"548","author":"Xu T.","year":"2017","unstructured":"Xu T.; Stewart K.M.; Wang X.; Liu K.; Xie M.; Ryu J.K.; Li K.; Ma T.; Wang H.; Ni L.; Zhu S.; Cao N.; Zhu D.; Zhang Y.; Akassoglou K.; Dong C.; Driggers E.M.; Ding S.; Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature  2017,548(7666),228-233","journal-title":"Nature"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"112153","DOI":"10.1016\/j.celrep.2023.112153","volume":"42","author":"Soriano-Baguet L.","year":"2023","unstructured":"Soriano-Baguet L.; Grusdat M.; Kurniawan H.; Benzarti M.; Binsfeld C.; Ewen A.; Longworth J.; Bonetti L.; Guerra L.; Franchina D.G.; Kobayashi T.; Horkova V.; Verschueren C.; Helgueta S.; G\u00e9rard D.; More T.H.; Henne A.; Dostert C.; Farinelle S.; Lesur A.; G\u00e9rardy J.J.; J\u00e4ger C.; Mittelbronn M.; Sinkkonen L.; Hiller K.; Meiser J.; Brenner D.; Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions. Cell Rep  2023,42(3),112153","journal-title":"Cell Rep"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/sj.onc.1209594","volume":"25","author":"King A.","year":"2006","unstructured":"King A.; Selak M.A.; Gottlieb E.; Succinate dehydrogenase and fumarate hydratase: Linking mitochondrial dysfunction and cancer. Oncogene  2006,25(34),4675-4682","journal-title":"Oncogene"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ni.3796","volume":"18","author":"Liu P.S.","year":"2017","unstructured":"Liu P.S.; Wang H.; Li X.; Chao T.; Teav T.; Christen S.; Di Conza G.; Cheng W.C.; Chou C.H.; Vavakova M.; Muret C.; Debackere K.; Mazzone M.; Huang H.D.; Fendt S.M.; Ivanisevic J.; Ho P.C.; \u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol  2017,18(9),985-994","journal-title":"Nat Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"676553","DOI":"10.3389\/fnins.2021.676553","volume":"15","author":"Li K.","year":"2021","unstructured":"Li K.; Zheng Y.; Wang X.; The potential relationship between hif-1\u03b1 and amino acid metabolism after hypoxic ischemia and dual effects on neurons. Front Neurosci  2021,15,676553","journal-title":"Front Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"106015","DOI":"10.1016\/j.nbd.2023.106015","volume":"178","author":"Buonvicino D.","year":"2023","unstructured":"Buonvicino D.; Ranieri G.; Guasti D.; Pistolesi A.; La Rocca A.I.; Rapizzi E.; Chiarugi A.; Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis. Neurobiol Dis  2023,178,106015","journal-title":"Neurobiol Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.cmet.2017.09.014","volume":"26","author":"Bantug G.R.","year":"2017","unstructured":"Bantug G.R.; Hess C.; The burgeoning world of immunometabolites: Th17 cells take center stage. Cell Metab  2017,26(4),588-590","journal-title":"Cell Metab"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/s41598-022-07024-7","volume":"12","author":"Kabiraj P.","year":"2022","unstructured":"Kabiraj P.; Grund E.M.; Clarkson B.D.S.; Johnson R.K.; LaFrance-Corey R.G.; Lucchinetti C.F.; Howe C.L.; Teriflunomide shifts the astrocytic bioenergetic profile from oxidative metabolism to glycolysis and attenuates TNF\u03b1-induced inflammatory responses. Sci Rep  2022,12(1),3049","journal-title":"Sci Rep"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"eaao5563","DOI":"10.1126\/scitranslmed.aao5563","volume":"11","author":"Klotz L.","year":"2019","unstructured":"Klotz L.; Eschborn M.; Lindner M.; Liebmann M.; Herold M.; Janoschka C.; Torres Garrido B.; Schulte-Mecklenbeck A.; Gross C.C.; Breuer J.; Hundehege P.; Posevitz V.; Pignolet B.; Nebel G.; Glander S.; Freise N.; Austermann J.; Wirth T.; Campbell G.R.; Schneider-Hohendorf T.; Eveslage M.; Brassat D.; Schwab N.; Loser K.; Roth J.; Busch K.B.; Stoll M.; Mahad D.J.; Meuth S.G.; Turner T.; Bar-Or A.; Wiendl H.; Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects. Sci Transl Med  2019,11(490),eaao5563","journal-title":"Sci Transl Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbacli.2016.10.004","volume":"6","author":"De Riccardis L.","year":"2016","unstructured":"De Riccardis L.; Ferramosca A.; Danieli A.; Trianni G.; Zara V.; De Robertis F.; Maffia M.; Metabolic response to glatiramer acetate therapy in multiple sclerosis patients. BBA Clin  2016,6,131-137","journal-title":"BBA Clin"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1523\/JNEUROSCI.0545-23.2023","volume":"43","author":"Nemati S.","year":"2023","unstructured":"Nemati S.; Kondiles B.R.; Wheeler S.; The contributions of the mTOR complexes: How does regional and temporal heterogeneity affect myelination and remyelination? J Neurosci  2023,43(31),5590-5592","journal-title":"J Neurosci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/cells8080825","volume":"8","author":"Gruchot J.","year":"2019","unstructured":"Gruchot J.; Weyers V.; G\u00f6ttle P.; F\u00f6rster M.; Hartung H.P.; K\u00fcry P.; Kremer D.; The molecular basis for remyelination failure in multiple sclerosis. Cells  2019,8(8),825","journal-title":"Cells"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41398-021-01443-2","volume":"11","author":"Guo Y.","year":"2021","unstructured":"Guo Y.; Zhu X.; Zeng M.; Qi L.; Tang X.; Wang D.; Zhang M.; Xie Y.; Li H.; Yang X.; Chen D.; A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota. Transl Psychiatry  2021,11(1),328","journal-title":"Transl Psychiatry"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fncel.2019.00188","volume":"13","author":"Sanguinetti E.","year":"2019","unstructured":"Sanguinetti E.; Guzzardi M.A.; Panetta D.; Tripodi M.; De Sena V.; Quaglierini M.; Burchielli S.; Salvadori P.A.; Iozzo P.; Combined effect of fatty diet and cognitive decline on brain metabolism, food intake, body weight, and counteraction by intranasal insulin therapy in 3\u00d7tg mice. Front Cell Neurosci  2019,13,188","journal-title":"Front Cell Neurosci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jneuroim.2018.05.010","volume":"322","author":"Dupree J.L.","year":"2018","unstructured":"Dupree J.L.; Feinstein D.L.; Influence of diet on axonal damage in the EAE mouse model of multiple sclerosis. J Neuroimmunol  2018,322,9-14","journal-title":"J Neuroimmunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.neuroscience.2013.07.055","volume":"250","author":"Soares E.","year":"2013","unstructured":"Soares E.; Prediger R.D.; Nunes S.; Castro A.A.; Viana S.D.; Lemos C.; De Souza C.M.; Agostinho P.; Cunha R.A.; Carvalho E.; Fontes Ribeiro C.A.; Reis F.; Pereira F.C.; Spatial memory impairments in a prediabetic rat model. Neuroscience  2013,250,565-577","journal-title":"Neuroscience"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/ijmm.2022.5191","volume":"50","author":"Kyriazis I.","year":"2022","unstructured":"Kyriazis I.; Vassi E.; Alvanou M.; Angelakis C.; Skaperda Z.; Tekos F.; Garikipati V.; Spandidos D.; Kouretas D.; The impact of diet upon mitochondrial physiology (Review). Int J Mol Med  2022,50(5),135","journal-title":"Int J Mol Med"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molmet.2018.04.004","volume":"12","author":"de Ligt M.","year":"2018","unstructured":"de Ligt M.; Bruls Y.M.H.; Hansen J.; Habets M.F.; Havekes B.; Nascimento E.B.M.; Moonen-Kornips E.; Schaart G.; Schrauwen-Hinderling V.B.; van Marken Lichtenbelt W.; Schrauwen P.; Resveratrol improves ex vivo mitochondrial function but does not affect insulin sensitivity or brown adipose tissue in first degree relatives of patients with type 2 diabetes. Mol Metab  2018,12,39-47","journal-title":"Mol Metab"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"12785","DOI":"10.14814\/phy2.12785","volume":"4","author":"Yoshino J.","year":"2016","unstructured":"Yoshino J.; Smith G.I.; Kelly S.C.; Julliand S.; Reeds D.N.; Mittendorfer B.; Effect of dietary n-3 PUFA supplementation on the muscle transcriptome in older adults. Physiol Rep  2016,4(11),12785","journal-title":"Physiol Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/7.1064","volume":"1","author":"Gianfrancesco M.","year":"2016","unstructured":"Gianfrancesco M.; Barcellos L.; Obesity and multiple sclerosis susceptibility: A review. J Neurol Neuromedicine  2016,1(7),1-5","journal-title":"J Neurol Neuromedicine"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/jamaneurol.2019.1997","volume":"76","author":"Huppke B.","year":"2019","unstructured":"Huppke B.; Ellenberger D.; Hummel H.; Stark W.; R\u00f6bl M.; G\u00e4rtner J.; Huppke P.; Association of obesity with multiple sclerosis risk and response to first-line disease modifying drugs in children. JAMA Neurol  2019,76(10),1157-1165","journal-title":"JAMA Neurol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"104647","DOI":"10.1016\/j.ebiom.2023.104647","volume":"93","author":"Zeng R.","year":"2023","unstructured":"Zeng R.; Jiang R.; Huang W.; Wang J.; Zhang L.; Ma Y.; Wu Y.; Meng M.; Lan H.; Lian Q.; Leung F.W.; Sha W.; Chen H.; Dissecting shared genetic architecture between obesity and multiple sclerosis. EBioMedicine  2023,93,104647","journal-title":"EBioMedicine"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/1028415X.2022.2146843","volume":"26","author":"Atabilen B.","year":"2023","unstructured":"Atabilen B.; Akdevelio\u011flu Y.; Effects of different dietary interventions in multiple sclerosis: A systematic review of evidence from 2018 to 2022. Nutr Neurosci  2023,26(12),1279-1291","journal-title":"Nutr Neurosci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1227431","DOI":"10.3389\/fnut.2023.1227431","volume":"10","author":"Ort\u00ed J.E.R.","year":"2023","unstructured":"Ort\u00ed J.E.R.; Cuerda-Ballester M.; Sanchis-Sanchis C.E.; Lajara R.J.M.; Navarro-Illana E.; Garc\u00eda P.M.P.; Exploring the impact of ketogenic diet on multiple sclerosis: Obesity, anxiety, depression, and the glutamate system. Front Nutr  2023,10,1227431","journal-title":"Front Nutr"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","volume":"93","author":"Brenton J.N.","year":"2022","unstructured":"Brenton J.N.; Lehner-Gulotta D.; Woolbright E.; Banwell B.; Bergqvist A.G.C.; Chen S.; Coleman R.; Conaway M.; Goldman M.D.; Phase II study of ketogenic diets in relapsing multiple sclerosis: Safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry  2022,93(6),637-644","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1212\/NXI.0000000000001102","volume":"9","author":"Bock M.","year":"2022","unstructured":"Bock M.; Steffen F.; Zipp F.; Bittner S.; Impact of dietary intervention on serum neurofilament light chain in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm  2022,9(1),1102","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/nu12123792","volume":"12","author":"Benlloch M.","year":"2020","unstructured":"Benlloch M.; Cuerda Ballester M.; Drehmer E.; Platero J.L.; Carrera-Juli\u00e1 S.; L\u00f3pez-Rodr\u00edguez M.M.; Ceron J.J.; Tvarijonaviciute A.; Navarro M.\u00c1.; Moreno M.L.; de la Rubia Ort\u00ed J.E.; Possible reduction of cardiac risk after supplementation with epigallocatechin gallate and increase of ketone bodies in the blood in patients with multiple sclerosis. a pilot study. Nutrients  2020,12(12),3792","journal-title":"Nutrients"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/nu12020305","volume":"12","author":"Platero J.L.","year":"2020","unstructured":"Platero J.L.; Cuerda-Ballester M.; Ib\u00e1\u00f1ez V.; Sancho D.; Lopez-Rodr\u00edguez M.M.; Drehmer E.; de la Rubia Ort\u00ed J.E.; The impact of coconut oil and epigallocatechin gallate on the levels of il-6, anxiety and disability in multiple sclerosis patients. Nutrients  2020,12(2),305","journal-title":"Nutrients"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.msard.2018.05.002","volume":"23","author":"Fitzgerald K.C.","year":"2018","unstructured":"Fitzgerald K.C.; Vizthum D.; Henry-Barron B.; Schweitzer A.; Cassard S.D.; Kossoff E.; Hartman A.L.; Kapogiannis D.; Sullivan P.; Baer D.J.; Mattson M.P.; Appel L.J.; Mowry E.M.; Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. Mult Scler Relat Disord  2018,23,33-39","journal-title":"Mult Scler Relat Disord"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"102149","DOI":"10.1016\/j.msard.2020.102149","volume":"42","author":"Roman S.N.","year":"2020","unstructured":"Roman S.N.; Fitzgerald K.C.; Beier M.; Mowry E.M.; Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosis. Mult Scler Relat Disord  2020,42,102149","journal-title":"Mult Scler Relat Disord"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1087126","DOI":"10.3389\/fneur.2022.1087126","volume":"13","author":"Wingo B.C.","year":"2023","unstructured":"Wingo B.C.; Rinker J.R.; Green K.; Peterson C.M.; Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis. Front Neurol  2023,13,1087126","journal-title":"Front Neurol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"104124","DOI":"10.1016\/j.ebiom.2022.104124","volume":"82","author":"Fitzgerald K.C.","year":"2022","unstructured":"Fitzgerald K.C.; Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis. Exp Biol Med  2022,82,104124","journal-title":"Exp Biol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"1328426","DOI":"10.3389\/fnut.2023.1328426","volume":"10","author":"Lin X.","year":"2024","unstructured":"Lin X.; Wang S.; Gao Y.; The effects of intermittent fasting for patients with multiple sclerosis (MS): A systematic review. Front Nutr  2024,10,1328426","journal-title":"Front Nutr"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1022728","DOI":"10.3389\/fneur.2022.1022728","volume":"13","author":"Villa A.T.","year":"2023","unstructured":"Villa A.T.; Tu B.H.; Titcomb T.J.; Saxby S.M.; Shemirani F.; Ten Eyck P.; Rubenstein L.M.; Snetselaar L.G.; Wahls T.L.; Association between improved metabolic risk factors and perceived fatigue during dietary intervention trial in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES trial. Front Neurol  2023,13,1022728","journal-title":"Front Neurol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1177\/13524585231208330","volume":"29","author":"Chase E.","year":"2023","unstructured":"Chase E.; Chen V.; Martin K.; Lane M.; Wooliscroft L.; Adams C.; Rice J.; Silbermann E.; Hollen C.; Fryman A.; Purnell J.Q.; Vong C.; Orban A.; Horgan A.; Khan A.; Srikanth P.; Yadav V.; A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial. Mult Scler  2023,29(13),1659-1675","journal-title":"Mult Scler"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.msard.2016.07.001","volume":"9","author":"Yadav V.","year":"2016","unstructured":"Yadav V.; Marracci G.; Kim E.; Spain R.; Cameron M.; Overs S.; Riddehough A.; Li D.K.B.; McDougall J.; Lovera J.; Murchison C.; Bourdette D.; Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord  2016,9,80-90","journal-title":"Mult Scler Relat Disord"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.3390\/ijms251810009","volume":"25","author":"Navarrete-P\u00e9rez A.","year":"2024","unstructured":"Navarrete-P\u00e9rez A.; G\u00f3mez-Melero S.; Escribano B.M.; Galvao-Carmona A.; Conde-Gavil\u00e1n C.; Pe\u00f1a-Toledo M.\u00c1.; Villarrubia N.; Villar L.M.; T\u00fanez I.; Ag\u00fcera-Morales E.; Caballero-Villarraso J.; MIND diet impact on multiple sclerosis patients: Biochemical changes after nutritional intervention. Int J Mol Sci  2024,25(18),10009","journal-title":"Int J Mol Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40120-022-00325-z","volume":"11","author":"Noormohammadi M.","year":"2022","unstructured":"Noormohammadi M.; Ghorbani Z.; Naser Moghadasi A.; Saeedirad Z.; Shahemi S.; Ghanaatgar M.; Rezaeimanesh N.; Hekmatdoost A.; Ghaemi A.; Razeghi Jahromi S.; MIND diet adherence might be associated with a reduced odds of multiple sclerosis: Results from a case\u2013control study. Neurol Ther  2022,11(1),397-412","journal-title":"Neurol Ther"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1212\/WNL.0000000000201371","volume":"100","author":"Snetselaar L.G.","year":"2023","unstructured":"Snetselaar L.G.; Cheek J.J.; Fox S.S.; Healy H.S.; Schweizer M.L.; Bao W.; Kamholz J.; Titcomb T.J.; Efficacy of diet on fatigue and quality of life in multiple sclerosis. Neurology  2023,100(4),e357-e366","journal-title":"Neurology"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/09637486.2017.1417978","volume":"69","author":"D\u2019Alessandro A.","year":"2018","unstructured":"D\u2019Alessandro A.; De Pergola G.; The mediterranean diet: Its definition and evaluation of a priori dietary indexes in primary cardiovascular prevention. Int J Food Sci Nutr  2018,69(6),647-659","journal-title":"Int J Food Sci Nutr"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41387-018-0025-1","volume":"8","author":"Billingsley H.E.","year":"2018","unstructured":"Billingsley H.E.; Carbone S.; The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: An in-depth review of the PREDIMED. Nutr Diabetes  2018,8(1),13","journal-title":"Nutr Diabetes"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","volume":"28","author":"Arias-S\u00e1nchez R.A.","year":"2023","unstructured":"Arias-S\u00e1nchez R.A.; Torner L.; Fenton N.B.; Polyphenols and neurodegenerative diseases: Potential effects and mechanisms of neuroprotection. Molecules  2023,28(14),5415","journal-title":"Molecules"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"9139","DOI":"10.3390\/nu7115459","volume":"7","author":"Davis C.","year":"2015","unstructured":"Davis C.; Bryan J.; Hodgson J.; Murphy K.; Definition of the mediterranean diet; a literature review. Nutrients  2015,7(11),9139-9153","journal-title":"Nutrients"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1023\/A:1007529206050","volume":"15","author":"Menotti A.","year":"1999","unstructured":"Menotti A.; Kromhout D.; Blackburn H.; Fidanza F.; Buzina R.; Nissinen A.; Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study. Eur J Epidemiol  1999,15(6),507-515","journal-title":"Eur J Epidemiol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.maturitas.2023.107841","volume":"178","author":"Monllor-Tormos A.","year":"2023","unstructured":"Monllor-Tormos A.; Garc\u00eda-Vigara A.; Morgan O.; Garc\u00eda-P\u00e9rez M.\u00c1.; Mendoza N.; Tar\u00edn J.J.; Cano A.; Mediterranean diet for cancer prevention and survivorship. Maturitas  2023,178,107841","journal-title":"Maturitas"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3390\/nu12113342","volume":"12","author":"Papadaki A.","year":"2020","unstructured":"Papadaki A.; Nolen-Doerr E.; Mantzoros C.S.; The effect of the mediterranean diet on metabolic health: A systematic review and meta-analysis of controlled trials in adults. Nutrients  2020,12(11),3342","journal-title":"Nutrients"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/ijerph20021056","volume":"20","author":"Szypowska A.","year":"2023","unstructured":"Szypowska A.; Zato\u0144ska K.; Szuba A.; Regulska-Ilow B.; Dietary inflammatory index (DII)\u00ae and metabolic syndrome in the selected population of polish adults: Results of the pure poland sub-study. Int J Environ Res Public Health  2023,20(2),1056","journal-title":"Int J Environ Res Public Health"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1759091414568185","DOI":"10.1177\/1759091414568185","volume":"7","author":"Riccio P.","year":"2015","unstructured":"Riccio P.; Rossano R.; Nutrition facts in multiple sclerosis. ASN Neuro  2015,7(1),1759091414568185","journal-title":"ASN Neuro"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cell.2017.12.013","volume":"172","author":"Christ A.","year":"2018","unstructured":"Christ A.; G\u00fcnther P.; Lauterbach M.A.R.; Duewell P.; Biswas D.; Pelka K.; Scholz C.J.; Oosting M.; Haendler K.; Ba\u00dfler K.; Klee K.; Schulte-Schrepping J.; Ulas T.; Moorlag S.J.C.F.M.; Kumar V.; Park M.H.; Joosten L.A.B.; Groh L.A.; Riksen N.P.; Espevik T.; Schlitzer A.; Li Y.; Fitzgerald M.L.; Netea M.G.; Schultze J.L.; Latz E.; Western diet triggers NLRP3-dependent innate immune reprogramming. Cell  2018,172(1-2),162-175.e14","journal-title":"Cell"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.3390\/ijms20194716","volume":"20","author":"Tuttolomondo A.","year":"2019","unstructured":"Tuttolomondo A.; Simonetta I.; Daidone M.; Mogavero A.; Ortello A.; Pinto A.; Metabolic and vascular effect of the mediterranean diet. Int J Mol Sci  2019,20(19),4716","journal-title":"Int J Mol Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11357-019-00149-0","volume":"42","author":"Gensous N.","year":"2020","unstructured":"Gensous N.; Garagnani P.; Santoro A.; Giuliani C.; Ostan R.; Fabbri C.; Milazzo M.; Gentilini D.; di Blasio A.M.; Pietruszka B.; Madej D.; Bialecka-Debek A.; Brzozowska A.; Franceschi C.; Bacalini M.G.; One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: A pilot study from the NU-AGE project. Geroscience  2020,42(2),687-701","journal-title":"Geroscience"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13105-017-0552-6","volume":"73","author":"Arp\u00f3n A.","year":"2016","unstructured":"Arp\u00f3n A.; Riezu-Boj J.I.; Milagro F.I.; Marti A.; Razquin C.; Mart\u00ednez-Gonz\u00e1lez M.A.; Corella D.; Estruch R.; Casas R.; Fit\u00f3 M.; Ros E.; Salas-Salvad\u00f3 J.; Mart\u00ednez J.A.; Adherence to mediterranean diet is associated with methylation changes in inflammation-related genes in peripheral blood cells. J Physiol Biochem  2016,73(3),445-455","journal-title":"J Physiol Biochem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2018.11.001","volume":"49","author":"Davinelli S.","year":"2019","unstructured":"Davinelli S.; Trichopoulou A.; Corbi G.; De Vivo I.; Scapagnini G.; The potential nutrigeroprotective role of Mediterranean diet and its functional components on telomere length dynamics. Ageing Res Rev  2019,49,1-10","journal-title":"Ageing Res Rev"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2323752","DOI":"10.1080\/19490976.2024.2323752","volume":"16","author":"Park G.","year":"2024","unstructured":"Park G.; Kadyan S.; Hochuli N.; Pollak J.; Wang B.; Salazar G.; Chakrabarty P.; Efron P.; Sheffler J.; Nagpal R.; A modified Mediterranean-style diet enhances brain function via specific gut-microbiome-brain mechanisms. Gut Microbes  2024,16(1),2323752","journal-title":"Gut Microbes"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/nu17020336","volume":"17","author":"Christodoulou C.C.","year":"2025","unstructured":"Christodoulou C.C.; Pitsillides M.; Hadjisavvas A.; Zamba-Papanicolaou E.; Dietary intake, mediterranean and nordic diet adherence in alzheimer\u2019s disease and dementia: A systematic review. Nutrients  2025,17(2),336","journal-title":"Nutrients"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.clnesp.2024.09.020","volume":"64","author":"Vaziri Y.","year":"2024","unstructured":"Vaziri Y.; The mediterranean diet: A powerful defense against Alzheimer disease-A comprehensive review. Clin Nutr ESPEN  2024,64,160-167","journal-title":"Clin Nutr ESPEN"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40520-024-02718-6","volume":"36","author":"Nucci D.","year":"2024","unstructured":"Nucci D.; Sommariva A.; Degoni L.M.; Gallo G.; Mancarella M.; Natarelli F.; Savoia A.; Catalini A.; Ferranti R.; Pregliasco F.E.; Castaldi S.; Gianfredi V.; Association between Mediterranean diet and dementia and Alzheimer disease: A systematic review with meta-analysis. Aging Clin Exp Res  2024,36(1),77","journal-title":"Aging Clin Exp Res"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"112065","DOI":"10.1016\/j.exger.2022.112065","volume":"172","author":"Gregory S.","year":"2023","unstructured":"Gregory S.; Pullen H.; Ritchie C.W.; Shannon O.M.; Stevenson E.J.; Muniz-Terrera G.; Mediterranean diet and structural neuroimaging biomarkers of Alzheimer\u2019s and cerebrovascular disease: A systematic review. Exp Gerontol  2023,172,112065","journal-title":"Exp Gerontol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s13668-024-00539-7","volume":"13","author":"Ayten \u015e.","year":"2024","unstructured":"Ayten \u015e.; Bilici S.; Modulation of gut microbiota through dietary intervention in neuroinflammation and Alzheimer\u2019s and Parkinson\u2019s diseases. Curr Nutr Rep  2024,13(2),82-96","journal-title":"Curr Nutr Rep"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"100451","DOI":"10.1016\/j.jnha.2024.100451","volume":"29","author":"Zhao J.","year":"2025","unstructured":"Zhao J.; Peng Y.; Lin Z.; Gong Y.; Association between Mediterranean diet adherence and Parkinson\u2019s disease: A systematic review and meta-analysis. J Nutr Health Aging  2025,29(2),100451","journal-title":"J Nutr Health Aging"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ijms24010042","volume":"24","author":"Bisaglia M.","year":"2022","unstructured":"Bisaglia M.; Mediterranean diet and parkinson\u2019s disease. Int J Mol Sci  2022,24(1),42","journal-title":"Int J Mol Sci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.3390\/nu16142181","volume":"16","author":"Seelarbokus B.A.","year":"2024","unstructured":"Seelarbokus B.A.; Menozzi E.; Schapira A.H.V.; Kalea A.Z.; Macnaughtan J.; Mediterranean diet adherence, gut microbiota and Parkinson\u2019s disease: A systematic review. Nutrients  2024,16(14),2181","journal-title":"Nutrients"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"120166","DOI":"10.1016\/j.jns.2022.120166","volume":"434","author":"Solch R.J.","year":"2022","unstructured":"Solch R.J.; Aigbogun J.O.; Voyiadjis A.G.; Talkington G.M.; Darensbourg R.M.; O\u2019Connell S.; Pickett K.M.; Perez S.R.; Maraganore D.M.; Mediterranean diet adherence, gut microbiota, and Alzheimer\u2019s or Parkinson\u2019s disease risk: A systematic review. J Neurol Sci  2022,434,120166","journal-title":"J Neurol Sci"},{"key":"ref=139","volume":"Vol. 1-6","author":"Abbasi H.","year":"2023","unstructured":"Abbasi H.;  Mediterranean-like diets in multiple sclerosis: A systematic review  2023,Vol. 1-6","journal-title":"Mediterranean-like diets in multiple sclerosis: A systematic review"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/ana.25244","volume":"83","author":"Tankou S.K.","year":"2018","unstructured":"Tankou S.K.; Regev K.; Healy B.C.; Tjon E.; Laghi L.; Cox L.M.; Kivis\u00e4kk P.; Pierre I.V.; Hrishikesh L.; Gandhi R.; Cook S.; Glanz B.; Stankiewicz J.; Weiner H.L.; A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol  2018,83(6),1147-1161","journal-title":"Ann Neurol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41598-018-36941-9","volume":"9","author":"Chriett S.","year":"2019","unstructured":"Chriett S.; D\u0105bek A.; Wojtala M.; Vidal H.; Balcerczyk A.; Pirola L.; Prominent action of butyrate over \u03b2-hydroxybutyrate as histone deacetylase inhibitor, transcriptional modulator and anti-inflammatory molecule. Sci Rep  2019,9(1),742","journal-title":"Sci Rep"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"Duscha A.","year":"2020","unstructured":"Duscha A.; Gisevius B.; Hirschberg S.; Yissachar N.; Stangl G.I.; Dawin E.; Bader V.; Haase S.; Kaisler J.; David C.; Schneider R.; Troisi R.; Zent D.; Hegelmaier T.; Dokalis N.; Gerstein S.; Del Mare-Roumani S.; Amidror S.; Staszewski O.; Poschmann G.; St\u00fchler K.; Hirche F.; Balogh A.; Kempa S.; Tr\u00e4ger P.; Zaiss M.M.; Holm J.B.; Massa M.G.; Nielsen H.B.; Faissner A.; Lukas C.; Gatermann S.G.; Scholz M.; Przuntek H.; Prinz M.; Forslund S.K.; Winklhofer K.F.; M\u00fcller D.N.; Linker R.A.; Gold R.; Haghikia A.; Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell  2020,180(6),1067-1080.e16","journal-title":"Cell"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1376838","DOI":"10.3389\/fimmu.2024.1376838","volume":"15","author":"Tang C.","year":"2024","unstructured":"Tang C.; Iron metabolism disorder and multiple sclerosis: A comprehensive analysis. Front Immunol  2024,15,1376838","journal-title":"Front Immunol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"104934","DOI":"10.1016\/j.msard.2023.104934","volume":"78","author":"Zierfuss B.","year":"2023","unstructured":"Zierfuss B.; Wang Z.; Jackson A.N.; Moezzi D.; Yong V.W.; Iron in multiple sclerosis \u2013 Neuropathology, immunology, and real-world considerations. Mult Scler Relat Disord  2023,78,104934","journal-title":"Mult Scler Relat Disord"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fnins.2019.00086","volume":"13","author":"Siotto M.","year":"2019","unstructured":"Siotto M.; Filippi M.M.; Simonelli I.; Landi D.; Oxidative stress related to iron metabolism in relapsing remitting multiple sclerosis patients with low disability. Front Neurosci  2019,13,86","journal-title":"Front Neurosci"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/606807","volume":"2011","author":"Khalil M.","year":"2011","unstructured":"Khalil M.; Teunissen C.; Langkammer C.; Iron and neurodegeneration in multiple sclerosis. Mult Scler Int  2011,2011,1-6","journal-title":"Mult Scler Int"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3390\/ijms26020845","volume":"26","author":"Terracina S.","year":"2025","unstructured":"Terracina S.; Alcohol consumption and autoimmune diseases. Int J Mol Sci  2025,26(2),845","journal-title":"Int J Mol Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"22158","DOI":"10.1038\/s41598-022-26409-2","volume":"12","author":"Dreyer-Alster S.","year":"2022","unstructured":"Dreyer-Alster S.; Achiron A.; Giovannoni G.; Jacobs B.M.; Dobson R.; No evidence for an association between alcohol consumption and Multiple Sclerosis risk: A UK Biobank study. Sci Rep  2022,12(1),22158","journal-title":"Sci Rep"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"72","DOI":"10.18502\/cjn.v22i2.13331","volume":"22","author":"Mortazavi S.H.","year":"2023","unstructured":"Mortazavi S.H.; Moghadasi A.N.; Almasi-Hashiani A.; Sahraian M.A.; Goudarzi H.; Eskandarieh S.; Waterpipe and cigarette smoking and drug and alcohol consumption, and the risk of primary progressive multiple sclerosis: A population-based case-control study. Curr J Neurol  2023,22(2),72-81","journal-title":"Curr J Neurol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"567","DOI":"10.34172\/aim.2023.83","volume":"26","author":"Malekifar P.","year":"2023","unstructured":"Malekifar P.; Nedjat S.; Abdollahpour I.; Nazemipour M.; Malekifar S.; Mansournia M.A.; Impact of alcohol consumption on multiple sclerosis using model-based standardization and misclassification adjustment via probabilistic bias analysis. Arch Iran Med  2023,26(10),567-574","journal-title":"Arch Iran Med"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/1352458512448108","volume":"19","author":"Massa J.","year":"2013","unstructured":"Massa J.; O\u2019Reilly E.J.; Munger K.L.; Ascherio A.; Caffeine and alcohol intakes have no association with risk of multiple sclerosis. Mult Scler  2013,19(1),53-58","journal-title":"Mult Scler"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/13524585221127414","volume":"29","author":"Katz Sand I.","year":"2023","unstructured":"Katz Sand I.; Levy S.; Fitzgerald K.; Sorets T.; Sumowski J.F.; Mediterranean diet is linked to less objective disability in multiple sclerosis. Mult Scler  2023,29(2),248-260","journal-title":"Mult Scler"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"882426","DOI":"10.3389\/fnut.2022.882426","volume":"9","author":"Felicetti F.","year":"2022","unstructured":"Felicetti F.; Tommasin S.; Petracca M.; De Giglio L.; Gurreri F.; Ianniello A.; Nistri R.; Pozzilli C.; Ruggieri S.; Eating hubs in multiple sclerosis: Exploring the relationship between mediterranean diet and disability status in Italy. Front Nutr  2022,9,882426","journal-title":"Front Nutr"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/nu16060880","volume":"16","author":"Bronzini M.","year":"2024","unstructured":"Bronzini M.; Maglione A.; Rosso R.; Masuzzo F.; Matta M.; Meroni R.; Rolla S.; Clerico M.; Lower multiple sclerosis severity score is associated with higher adherence to mediterranean diet in subjects with multiple sclerosis from northwestern Italy. Nutrients  2024,16(6),880","journal-title":"Nutrients"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/13524585231181841","volume":"29","author":"Alfredsson L.","year":"2023","unstructured":"Alfredsson L.; Olsson T.; Hedstr\u00f6m A.K.; Inverse association between Mediterranean diet and risk of multiple sclerosis. Mult Scler  2023,29(9),1118-1125","journal-title":"Mult Scler"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/jn\/nxz089","volume":"149","author":"Black L.J.","year":"2019","unstructured":"Black L.J.; Baker K.; Ponsonby A.L.; van der Mei I.; Lucas R.M.; Pereira G.; A higher mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of australian adults. J Nutr  2019,149(8),1385-1392","journal-title":"J Nutr"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3945\/ajcn.113.060582","volume":"98","author":"Casta\u00f1er O.","year":"2013","unstructured":"Casta\u00f1er O.; Corella D.; Covas M.I.; Sorl\u00ed J.V.; Subirana I.; Flores-Mateo G.; Nonell L.; Bull\u00f3 M.; de la Torre R.; Portol\u00e9s O.; Fit\u00f3 M.; In vivo transcriptomic profile after a Mediterranean diet in high-cardiovascular risk patients: A randomized controlled trial. Am J Clin Nutr  2013,98(3),845-853","journal-title":"Am J Clin Nutr"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1177\/0271678X211067133","volume":"42","author":"Zhang Y.","year":"2022","unstructured":"Zhang Y.; Li F.; Chen C.; Li Y.; Xie W.; Huang D.; Zhai X.; Yu W.; Wan J.; Li P.; RAGE-mediated T cell metabolic reprogramming shapes T cell inflammatory response after stroke. J Cereb Blood Flow Metab  2022,42(6),952-965","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.afres.2022.100086","volume":"2","author":"Sudha M.","year":"2022","unstructured":"Sudha M.; Banita A.K.; Ram A.K.; Bhatia A.; Effect of dietary AGEs on the transcriptional profile of peripheral blood lymphocytes. Applied. Food Res  2022,2(1),100086","journal-title":"Food Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/antiox10020328","volume":"10","author":"Cannataro R.","year":"2021","unstructured":"Cannataro R.; Fazio A.; La Torre C.; Caroleo M.C.; Cione E.; Polyphenols in the mediterranean diet: From dietary sources to microrna modulation. Antioxidants  2021,10(2),328","journal-title":"Antioxidants"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bioorg.2018.10.051","volume":"83","author":"Baek S.C.","year":"2019","unstructured":"Baek S.C.; Park M.H.; Ryu H.W.; Lee J.P.; Kang M.G.; Park D.; Park C.M.; Oh S.R.; Kim H.; Rhamnocitrin isolated from Prunus padus var. seoulensis: A potent and selective reversible inhibitor of human monoamine oxidase A. Bioorg Chem  2019,83,317-325","journal-title":"Bioorg Chem"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"112668","DOI":"10.1016\/j.biopha.2022.112668","volume":"147","author":"Tayab M.A.","year":"2022","unstructured":"Tayab M.A.; Islam M.N.; Chowdhury K.A.A.; Tasnim F.M.; Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression. Biomed Pharmacother  2022,147,112668","journal-title":"Biomed Pharmacother"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1016\/j.bmc.2016.05.011","volume":"24","author":"Bhakkiyalakshmi E.","year":"2016","unstructured":"Bhakkiyalakshmi E.; Dineshkumar K.; Karthik S.; Sireesh D.; Hopper W.; Paulmurugan R.; Ramkumar K.M.; Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface. Bioorg Med Chem  2016,24(16),3378-3386","journal-title":"Bioorg Med Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/mmr.2016.5259","volume":"14","author":"Si T.L.","year":"2016","unstructured":"Si T.L.; Liu Q.I.; Ren Y.U.F.E.I.; Li H.U.I.; Xu X.Y.; Li E.R.H.U.; Pan S.I.Y.I.; Zhang J.L.; Wang K.X.; Enhanced anti-inflammatory effects of DHA and quercetin in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-\u03baB and MAPK activation. Mol Med Rep  2016,14(1),499-508","journal-title":"Mol Med Rep"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13167-020-00217-y","volume":"11","author":"Samec M.","year":"2020","unstructured":"Samec M.; Liskova A.; Koklesova L.; Samuel S.M.; Zhai K.; Buhrmann C.; Varghese E.; Abotaleb M.; Qaradakhi T.; Zulli A.; Kello M.; Mojzis J.; Zubor P.; Kwon T.K.; Shakibaei M.; B\u00fcsselberg D.; Sarria G.R.; Golubnitschaja O.; Kubatka P.; Flavonoids against the Warburg phenotype\u2014concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J  2020,11(3),377-398","journal-title":"EPMA J"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.3390\/nu14153112","volume":"14","author":"Khalil M.","year":"2022","unstructured":"Khalil M.; Shanmugam H.; Abdallah H.; John Britto J.S.; Galerati I.; G\u00f3mez-Ambrosi J.; Fr\u00fchbeck G.; Portincasa P.; The potential of the mediterranean diet to improve mitochondrial function in experimental models of obesity and metabolic syndrome. Nutrients  2022,14(15),3112","journal-title":"Nutrients"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.3390\/nu14214533","volume":"14","author":"Grubi\u0107 Kezele T.","year":"2022","unstructured":"Grubi\u0107 Kezele T.; \u0106urko-Cofek B.; Neuroprotective panel of olive polyphenols: Mechanisms of action, anti-demyelination, and anti-stroke properties. Nutrients  2022,14(21),4533","journal-title":"Nutrients"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"Lagouge M.","year":"2006","unstructured":"Lagouge M.; Argmann C.; Gerhart-Hines Z.; Meziane H.; Lerin C.; Daussin F.; Messadeq N.; Milne J.; Lambert P.; Elliott P.; Geny B.; Laakso M.; Puigserver P.; Auwerx J.; Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1. Cell  2006,127(6),1109-1122","journal-title":"Cell"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-140981","volume":"44","author":"Walker J.M.","year":"2015","unstructured":"Walker J.M.; Klakotskaia D.; Ajit D.; Weisman G.A.; Wood W.G.; Sun G.Y.; Serfozo P.; Simonyi A.; Schachtman T.R.; Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer\u2019s disease mouse model. J Alzheimers Dis  2015,44(2),561-572","journal-title":"J Alzheimers Dis"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","volume":"285","author":"Vingtdeux V.","year":"2010","unstructured":"Vingtdeux V.; Giliberto L.; Zhao H.; Chandakkar P.; Wu Q.; Simon J.E.; Janle E.M.; Lobo J.; Ferruzzi M.G.; Davies P.; Marambaud P.; AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem  2010,285(12),9100-9113","journal-title":"J Biol Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/nu10050642","volume":"10","author":"Kujawska M.","year":"2018","unstructured":"Kujawska M.; Jodynis-Liebert J.; Polyphenols in Parkinson\u2019s disease: A systematic review of in vivo studies. Nutrients  2018,10(5),642","journal-title":"Nutrients"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.3390\/ijms24087247","volume":"24","author":"La Rosa G.","year":"2023","unstructured":"La Rosa G.; Lonardo M.S.; Cacciapuoti N.; Muscariello E.; Guida B.; Faraonio R.; Santillo M.; Damiano S.; Dietary polyphenols, microbiome, and multiple sclerosis: From molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence. Int J Mol Sci  2023,24(8),7247","journal-title":"Int J Mol Sci"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0006-2952(02)01609-X","volume":"65","author":"Hendriks J.J.A.","year":"2003","unstructured":"Hendriks J.J.A.; de Vries H.E.; van der Pol S.M.A.; van den Berg T.K.; van Tol E.A.F.; Dijkstra C.D.; Flavonoids inhibit myelin phagocytosis by macrophages; a structure\u2013activity relationship study. Biochem Pharmacol  2003,65(5),877-885","journal-title":"Biochem Pharmacol"},{"key":"ref=174","first-page":"7563","volume":"63","author":"Fang M.Z.","year":"2003","unstructured":"Fang M.Z.; Wang Y.; Ai N.; Hou Z.; Sun Y.; Lu H.; Welsh W.; Yang C.S.; Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res  2003,63(22),7563-7570","journal-title":"Cancer Res"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/carcin\/bgq285","volume":"32","author":"Nandakumar V.","year":"2011","unstructured":"Nandakumar V.; Vaid M.; Katiyar S.K.; (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1\/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis  2011,32(4),537-544","journal-title":"Carcinogenesis"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"25982","DOI":"10.1371\/journal.pone.0025982","volume":"6","author":"Arola-Arnal A.","year":"2011","unstructured":"Arola-Arnal A.; Blad\u00e9 C.; Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLoS One  2011,6(10),25982","journal-title":"PLoS One"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2174\/157340606776056133","volume":"2","author":"Neckers L.","year":"2006","unstructured":"Neckers L.; Trepel J.; Lee S.; Chung E.J.; Lee M.J.; Jung Y-J.; Marcu M.; Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem  2006,2(2),169-174","journal-title":"Med Chem"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/or.2010.1097","volume":"25","year":"2011","unstructured":"Tseng; Chen, Y.R.; Tseng, T.H. Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep  2011,25(2),583-591","journal-title":"Oncol Rep"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"2250229","DOI":"10.1002\/eji.202250229","volume":"53","author":"Diaz-Marugan L.","year":"2023","unstructured":"Diaz-Marugan L.; Kantsj\u00f6 J.B.; Rutsch A.; Ronchi F.; Microbiota, diet, and the gut\u2013brain axis in multiple sclerosis and stroke. Eur J Immunol  2023,53(11),2250229","journal-title":"Eur J Immunol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"953196","DOI":"10.3389\/fimmu.2022.953196","volume":"13","author":"Suriano F.","year":"2022","unstructured":"Suriano F.; Nystr\u00f6m E.E.L.; Sergi D.; Gustafsson J.K.; Diet, microbiota, and the mucus layer: The guardians of our health. Front Immunol  2022,13,953196","journal-title":"Front Immunol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","volume":"21","author":"Mascanfroni I.D.","year":"2015","unstructured":"Mascanfroni I.D.; Takenaka M.C.; Yeste A.; Patel B.; Wu Y.; Kenison J.E.; Siddiqui S.; Basso A.S.; Otterbein L.E.; Pardoll D.M.; Pan F.; Priel A.; Clish C.B.; Robson S.C.; Quintana F.J.; Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1. Nat Med  2015,21(6),638-646","journal-title":"Nat Med"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"75139","DOI":"10.1371\/journal.pone.0075139","volume":"8","author":"Zou T.","year":"2013","unstructured":"Zou T.; Yang Y.; Xia F.; Huang A.; Gao X.; Fang D.; Xiong S.; Zhang J.; Resveratrol inhibits CD4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One  2013,8(9),75139","journal-title":"PLoS One"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00011-023-01728-w","volume":"72","author":"Jiang T.T.","year":"2023","unstructured":"Jiang T.T.; Ji C.L.; Yu L.J.; Song M.K.; Li Y.; Liao Q.; Wei T.; Olatunji O.J.; Zuo J.; Han J.; Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1\u03b1. Inflamm Res  2023,72(5),1021-1035","journal-title":"Inflamm Res"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"eaal3024","DOI":"10.1126\/scisignal.aal3024","volume":"10","author":"Craveiro M.","year":"2017","unstructured":"Craveiro M.; Cretenet G.; Mongellaz C.; Matias M.I.; Caron O.; de Lima M.C.P.; Zimmermann V.S.; Solary E.; Dardalhon V.; Duli\u0107 V.; Taylor N.; Resveratrol stimulates the metabolic reprogramming of human CD4 + T cells to enhance effector function. Sci Signal  2017,10(501),eaal3024","journal-title":"Sci Signal"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s12035-017-0510-x","volume":"55","author":"Rosa P.M.","year":"2018","unstructured":"Rosa P.M.; Martins L.A.M.; Souza D.O.; Quincozes-Santos A.; Glioprotective effect of resveratrol: An emerging therapeutic role for oligodendroglial cells. Mol Neurobiol  2018,55(4),2967-2978","journal-title":"Mol Neurobiol"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2174\/1871530314666140709093305","volume":"14","author":"Russo M.","year":"2014","unstructured":"Russo M.; Sansone L.; Polletta L.; Runci A.; Rashid M.; Santis E.; Vernucci E.; Carnevale I.; Tafani M.; Sirtuins and resveratrol-derived compounds: A model for understanding the beneficial effects of the Mediterranean diet. Endocr Metab Immune Disord Drug Targets  2014,14(4),300-308","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/nu9070751","volume":"9","author":"Lan F.","year":"2017","unstructured":"Lan F.; Weikel K.; Cacicedo J.; Ido Y.; Resveratrol-induced AMP-activated protein kinase activation is cell-type dependent: Lessons from basic research for clinical application. Nutrients  2017,9(7),751","journal-title":"Nutrients"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"9199","DOI":"10.1371\/journal.pone.0009199","volume":"5","author":"Ghosh H.S.","year":"2010","unstructured":"Ghosh H.S.; McBurney M.; Robbins P.D.; SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One  2010,5(2),9199","journal-title":"PLoS One"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2007.03.051","volume":"566","author":"De Stefano D.","year":"2007","unstructured":"De Stefano D.; Maiuri M.C.; Simeon V.; Grassia G.; Soscia A.; Cinelli M.P.; Carnuccio R.; Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-\u03b3. Eur J Pharmacol  2007,566(1-3),192-199","journal-title":"Eur J Pharmacol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00210-005-1078-y","volume":"371","author":"Maiuri M.C.","year":"2005","unstructured":"Maiuri M.C.; De Stefano D.; Di Meglio P.; Irace C.; Savarese M.; Sacchi R.; Cinelli M.P.; Carnuccio R.; Hydroxytyrosol, a phenolic compound from virgin olive oil, prevents macrophage activation. Naunyn Schmiedebergs Arch Pharmacol  2005,371(6),457-465","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/ptr.8126","volume":"38","author":"Patwardhan R.S.","year":"2024","unstructured":"Patwardhan R.S.; Gohil D.; Singh B.; Kumar B.K.; Purohit V.; Thoh M.; Checker R.; Gardi N.; Gota V.; Kutala V.K.; Patwardhan S.; Sharma D.; Sandur S.K.; Mitochondrial\u2010targeted curcumin inhibits T\u2010cell activation via Nrf2 and inhibits graft\u2010versus\u2010host\u2010disease in a mouse model. Phytother Res  2024,38(3),1555-1573","journal-title":"Phytother Res"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phrs.2019.03.005","volume":"143","author":"de Pablos R.M.","year":"2019","unstructured":"de Pablos R.M.; Espinosa-Oliva A.M.; Hornedo-Ortega R.; Cano M.; Arguelles S.; Hydroxytyrosol protects from aging process via AMPK and autophagy; a review of its effects on cancer, metabolic syndrome, osteoporosis, immune-mediated and neurodegenerative diseases. Pharmacol Res  2019,143,58-72","journal-title":"Pharmacol Res"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6125638","volume":"2020","author":"Giacometti J.","year":"2020","unstructured":"Giacometti J.; Grubi\u0107-Kezele T.; Olive leaf polyphenols attenuate the clinical course of experimental autoimmune encephalomyelitis and provide neuroprotection by reducing oxidative stress, regulating microglia and sirt1, and preserving myelin integrity. Oxid Med Cell Longev  2020,2020,1-20","journal-title":"Oxid Med Cell Longev"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1152\/jn.00510.2016","volume":"116","author":"Wang D.","year":"2016","unstructured":"Wang D.; Li S.P.; Fu J.S.; Zhang S.; Bai L.; Guo L.; Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J Neurophysiol  2016,116(5),2173-2179","journal-title":"J Neurophysiol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fneur.2012.00084","volume":"3","author":"Fonseca-Kelly Z.","year":"2012","unstructured":"Fonseca-Kelly Z.; Nassrallah M.; Uribe J.; Khan R.S.; Dine K.; Dutt M.; Shindler K.S.; Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol  2012,3,84","journal-title":"Front Neurol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1007\/s12035-016-9891-5","volume":"54","author":"Ghaiad H.R.","year":"2017","unstructured":"Ghaiad H.R.; Nooh M.M.; El-Sawalhi M.M.; Shaheen A.A.; Resveratrol promotes remyelination in cuprizone model of multiple sclerosis: Biochemical and histological study. Mol Neurobiol  2017,54(5),3219-3229","journal-title":"Mol Neurobiol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"108560","DOI":"10.1016\/j.jnutbio.2020.108560","volume":"89","author":"Niu X.","year":"2021","unstructured":"Niu X.; Sang H.; Wang J.; Naringenin attenuates experimental autoimmune encephalomyelitis by protecting the intact of blood-brain barrier and controlling inflammatory cell migration. J Nutr Biochem  2021,89,108560","journal-title":"J Nutr Biochem"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11481-015-9617-x","volume":"11","author":"Ginwala R.","year":"2016","unstructured":"Ginwala R.; McTish E.; Raman C.; Singh N.; Nagarkatti M.; Nagarkatti P.; Sagar D.; Jain P.; Khan Z.K.; Apigenin, a natural flavonoid, attenuates eae severity through the modulation of dendritic cell and other immune cell functions. J Neuroimmune Pharmacol  2016,11(1),36-47","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.phyplu.2021.100139","volume":"1","author":"Singh A.","year":"2021","unstructured":"Singh A.; Upadhayay S.; Mehan S.; Inhibition of c-JNK\/p38MAPK signaling pathway by Apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: Evidence from CSF, blood plasma and brain samples. Phytomedicine Plus  2021,1(4),100139","journal-title":"Phytomedicine Plus"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbalip.2018.05.009","volume":"1863","author":"Busto R.","year":"2018","unstructured":"Busto R.; Serna J.; Perianes-Cachero A.; Quintana-Portillo R.; Garc\u00eda-Seisdedos D.; Canfr\u00e1n-Duque A.; Paino C.L.; Lerma M.; Casado M.E.; Mart\u00edn-Hidalgo A.; Arilla-Ferreiro E.; Lasunci\u00f3n M.A.; Pastor \u00d3.; Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis. Biochim Biophys Acta Mol Cell Biol Lipids  2018,1863(9),958-967","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"101891","DOI":"10.1016\/j.jchemneu.2020.101891","volume":"111","author":"Kiasalari Z.","year":"2021","unstructured":"Kiasalari Z.; Afshin-Majd S.; Baluchnejadmojarad T.; Azadi-Ahmadabadi E.; Esmaeil-Jamaat E.; Fahanik-Babaei J.; Fakour M.; Fereidouni F.; Ghasemi-Tarie R.; Jalalzade-Ogvar S.; Khodashenas V.; Sanaierad A.; Zahedi E.; Roghani M.; Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis. J Chem Neuroanat  2021,111,101891","journal-title":"J Chem Neuroanat"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11064-015-1571-8","volume":"40","author":"Ciftci O.","year":"2015","unstructured":"Ciftci O.; Ozcan C.; Kamisli O.; Cetin A.; Basak N.; Aytac B.; Hesperidin, a citrus flavonoid, has the ameliorative effects against experimental autoimmune encephalomyelitis (EAE) in a C57BL\/J6 mouse model. Neurochem Res  2015,40(6),1111-1120","journal-title":"Neurochem Res"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"114592","DOI":"10.1016\/j.intimp.2025.114592","volume":"154","author":"Liu L.","year":"2025","unstructured":"Liu L.; Zhao Y.; Bu J.; Peng S.; Li Y.; Su P.; Li Y.; Baicalin and kaempferol alleviates cuprizone-induced demyelination and microglial activation by inhibiting the STAT3 and NF-\u03baB signaling pathways. Int Immunopharmacol  2025,154,114592","journal-title":"Int Immunopharmacol"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10787-023-01399-3","volume":"32","author":"Sadek M.A.","year":"2024","unstructured":"Sadek M.A.; Rabie M.A.; El Sayed N.S.; Sayed H.M.; Kandil E.A.; Neuroprotective effect of curcumin against experimental autoimmune encephalomyelitis-induced cognitive and physical impairments in mice: An insight into the role of the AMPK\/SIRT1 pathway. Inflammopharmacology  2024,32(2),1499-1518","journal-title":"Inflammopharmacology"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12263-011-0255-5","volume":"7","author":"Schaffer S.","year":"2012","unstructured":"Schaffer S.; Halliwell B.; Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr  2012,7(2),99-109","journal-title":"Genes Nutr"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/10284150600637739","volume":"9","author":"Zini A.","year":"2006","unstructured":"Zini A.; Rio D.D.; Stewart A.J.; Mandrioli J.; Merelli E.; Sola P.; Nichelli P.; Serafini M.; Brighenti F.; Edwards C.A.; Crozier A.; Do flavan-3-ols from green tea reach the human brain? Nutr Neurosci  2006,9(1-2),57-61","journal-title":"Nutr Neurosci"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.3390\/nu12051531","volume":"12","author":"Grabska-Kobylecka I.","year":"2020","unstructured":"Grabska-Kobylecka I.; Kaczmarek-Bak J.; Figlus M.; Prymont-Przyminska A.; Zwolinska A.; Sarniak A.; Wlodarczyk A.; Glabinski A.; Nowak D.; The presence of caffeic acid in cerebrospinal fluid: Evidence that dietary polyphenols can cross the blood-brain barrier in humans. Nutrients  2020,12(5),1531","journal-title":"Nutrients"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3945\/ajcn.113.075309","volume":"101","author":"M\u00e4hler A.","year":"2015","unstructured":"M\u00e4hler A.; Steiniger J.; Bock M.; Klug L.; Parreidt N.; Lorenz M.; Zimmermann B.F.; Krannich A.; Paul F.; Boschmann M.; Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial. Am J Clin Nutr  2015,101(3),487-495","journal-title":"Am J Clin Nutr"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.intimp.2018.05.018","volume":"61","author":"Dolati S.","year":"2018","unstructured":"Dolati S.; Ahmadi M.; Rikhtegar R.; Babaloo Z.; Ayromlou H.; Aghebati-Maleki L.; Nouri M.; Yousefi M.; Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis. Int Immunopharmacol  2018,61,74-81","journal-title":"Int Immunopharmacol"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"103274","DOI":"10.1016\/j.msard.2021.103274","volume":"56","author":"Petracca M.","year":"2021","unstructured":"Petracca M.; Quarantelli M.; Moccia M.; Vacca G.; Satelliti B.; D\u2019Ambrosio G.; Carotenuto A.; Ragucci M.; Assogna F.; Capacchione A.; Lanzillo R.; Morra V.B.; ProspeCtive study to evaluate efficacy, safety and tolerability of dietary supplement of curcumin (BCM95) in subjects with active relapsing multiple sclerosis treated with subcutaneous interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial. Mult Scler Relat Disord  2021,56,103274","journal-title":"Mult Scler Relat Disord"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"155094","DOI":"10.1016\/j.phymed.2023.155094","volume":"121","author":"Hajiluian G.","year":"2023","unstructured":"Hajiluian G.; Karegar S.J.; Shidfar F.; Aryaeian N.; Salehi M.; Lotfi T.; Farhangnia P.; Heshmati J.; Delbandi A.A.; The effects of Ellagic acid supplementation on neurotrophic, inflammation, and oxidative stress factors, and indoleamine 2, 3-dioxygenase gene expression in multiple sclerosis patients with mild to moderate depressive symptoms: A randomized, triple-blind, placebo-controlled trial. Phytomedicine  2023,121,155094","journal-title":"Phytomedicine"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/cb500683c","volume":"10","author":"Fan J.","year":"2015","unstructured":"Fan J.; Teng X.; Liu L.; Mattaini K.R.; Looper R.E.; Vander Heiden M.G.; Rabinowitz J.D.; Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. ACS Chem Biol  2015,10(2),510-516","journal-title":"ACS Chem Biol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/ars.2019.7902","volume":"33","author":"Je\u017eek P.","year":"2020","unstructured":"Je\u017eek P.; 2-Hydroxyglutarate in cancer cells. Antioxid Redox Signal  2020,33(13),903-926","journal-title":"Antioxid Redox Signal"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"Zhao S.","year":"2009","unstructured":"Zhao S.; Lin Y.; Xu W.; Jiang W.; Zha Z.; Wang P.; Yu W.; Li Z.; Gong L.; Peng Y.; Ding J.; Lei Q.; Guan K.L.; Xiong Y.; Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science  2009,324(5924),261-265","journal-title":"Science"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41591-018-0095-6","volume":"24","author":"Bunse L.","year":"2018","unstructured":"Bunse L.; Pusch S.; Bunse T.; Sahm F.; Sanghvi K.; Friedrich M.; Alansary D.; Sonner J.K.; Green E.; Deumelandt K.; Kilian M.; Neftel C.; Uhlig S.; Kessler T.; von Landenberg A.; Berghoff A.S.; Marsh K.; Steadman M.; Zhu D.; Nicolay B.; Wiestler B.; Breckwoldt M.O.; Al-Ali R.; Karcher-Bausch S.; Bozza M.; Oezen I.; Kramer M.; Meyer J.; Habel A.; Eisel J.; Poschet G.; Weller M.; Preusser M.; Nadji-Ohl M.; Thon N.; Burger M.C.; Harter P.N.; Ratliff M.; Harbottle R.; Benner A.; Schrimpf D.; Okun J.; Herold-Mende C.; Turcan S.; Kaulfuss S.; Hess-Stumpp H.; Bieback K.; Cahill D.P.; Plate K.H.; H\u00e4nggi D.; Dorsch M.; Suv\u00e0 M.L.; Niemeyer B.A.; von Deimling A.; Wick W.; Platten M.; Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nat Med  2018,24(8),1192-1203","journal-title":"Nat Med"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"651317","DOI":"10.3389\/fcell.2021.651317","volume":"9","author":"Du X.","year":"2021","unstructured":"Du X.; Hu H.; The roles of 2-hydroxyglutarate. Front Cell Dev Biol  2021,9,651317","journal-title":"Front Cell Dev Biol"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature20165","volume":"540","author":"Tyrakis P.A.","year":"2016","unstructured":"Tyrakis P.A.; Palazon A.; Macias D.; Lee K.L.; Phan A.T.; Veli\u00e7a P.; You J.; Chia G.S.; Sim J.; Doedens A.; Abelanet A.; Evans C.E.; Griffiths J.R.; Poellinger L.; Goldrath A.W.; Johnson R.S.; S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. Nature  2016,540(7632),236-241","journal-title":"Nature"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"101501","DOI":"10.1016\/j.jbc.2021.101501","volume":"298","author":"Williams N.C.","year":"2022","unstructured":"Williams N.C.; Ryan D.G.; Costa A.S.H.; Mills E.L.; Jedrychowski M.P.; Cloonan S.M.; Frezza C.; O\u2019Neill L.A.; Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1\u03b1 in lipopolysaccharide-activated macrophages. J Biol Chem  2022,298(2),101501","journal-title":"J Biol Chem"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41401-019-0225-9","volume":"40","author":"Han C.","year":"2019","unstructured":"Han C.; Zheng J.; Sun L.; Yang H.; Cao Z.; Zhang X.; Zheng L.; Zhen X.; The oncometabolite 2-hydroxyglutarate inhibits microglial activation via the AMPK\/mTOR\/NF-\u03baB pathway. Acta Pharmacol Sin  2019,40(10),1292-1302","journal-title":"Acta Pharmacol Sin"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10545-012-9462-5","volume":"35","author":"Kranendijk M.","year":"2012","unstructured":"Kranendijk M.; Struys E.A.; Salomons G.S.; Van der Knaap M.S.; Jakobs C.; Progress in understanding 2\u2010hydroxyglutaric acidurias. J Inherit Metab Dis  2012,35(4),571-587","journal-title":"J Inherit Metab Dis"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0026-0495(92)90197-I","volume":"41","author":"Lai R.K.","year":"1992","unstructured":"Lai R.K.; Goldman P.; Urinary organic acid profiles in obese (ob\/ob) mice: Indications for the impaired \u03c9-oxidation of fatty acids. Metabolism  1992,41(1),97-105","journal-title":"Metabolism"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/2159-8290.CD-21-0218","volume":"13","author":"Thomas D.","year":"2023","unstructured":"Thomas D.; Wu M.; Nakauchi Y.; Zheng M.; Thompson-Peach C.A.L.; Lim K.; Landberg N.; K\u00f6hnke T.; Robinson N.; Kaur S.; Kutyna M.; Stafford M.; Hiwase D.; Reinisch A.; Peltz G.; Majeti R.; Dysregulated lipid synthesis by oncogenic idh1 mutation is a targetable synthetic lethal vulnerability. Cancer Discov  2023,13(2),496-515","journal-title":"Cancer Discov"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.numecd.2023.01.002","volume":"33","author":"Santos J.L.","year":"2023","unstructured":"Santos J.L.; Ruiz-Canela M.; Razquin C.; Clish C.B.; Guasch-Ferr\u00e9 M.; Babio N.; Corella D.; G\u00f3mez-Gracia E.; Fiol M.; Estruch R.; Lapetra J.; Fit\u00f3 M.; Aros F.; Serra-Majem L.; Liang L.; Mart\u00ednez M.\u00c1.; Toledo E.; Salas-Salvad\u00f3 J.; Hu F.B.; Mart\u00ednez-Gonz\u00e1lez M.A.; Circulating citric acid cycle metabolites and risk of cardiovascular disease in the PREDIMED study. Nutr Metab Cardiovasc Dis  2023,33(4),835-843","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fneur.2014.00250","volume":"5","author":"Mathur D.","year":"2014","unstructured":"Mathur D.; L\u00f3pez-Rodas G.; Casanova B.; Marti M.B.; Perturbed glucose metabolism: Insights into multiple sclerosis pathogenesis. Front Neurol  2014,5,250","journal-title":"Front Neurol"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12013-013-9750-1","volume":"68","author":"Akram M.","year":"2014","unstructured":"Akram M.; Citric acid cycle and role of its intermediates in metabolism. Cell Biochem Biophys  2014,68(3),475-478","journal-title":"Cell Biochem Biophys"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","volume":"21","author":"Batchuluun B.","year":"2022","unstructured":"Batchuluun B.; Pinkosky S.L.; Steinberg G.R.; Lipogenesis inhibitors: Therapeutic opportunities and challenges. Nat Rev Drug Discov  2022,21(4),283-305","journal-title":"Nat Rev Drug Discov"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"Everts B.","year":"2014","unstructured":"Everts B.; Amiel E.; Huang S.C.C.; Smith A.M.; Chang C.H.; Lam W.Y.; Redmann V.; Freitas T.C.; Blagih J.; van der Windt G.J.W.; Artyomov M.N.; Jones R.G.; Pearce E.L.; Pearce E.J.; TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u025b supports the anabolic demands of dendritic cell activation. Nat Immunol  2014,15(4),323-332","journal-title":"Nat Immunol"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"Lampropoulou V.","year":"2016","unstructured":"Lampropoulou V.; Sergushichev A.; Bambouskova M.; Nair S.; Vincent E.E.; Loginicheva E.; Cervantes-Barragan L.; Ma X.; Huang S.C.C.; Griss T.; Weinheimer C.J.; Khader S.; Randolph G.J.; Pearce E.J.; Jones R.G.; Diwan A.; Diamond M.S.; Artyomov M.N.; Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab  2016,24(1),158-166","journal-title":"Cell Metab"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/JLB.3MIR1118-415R","volume":"106","author":"Patil N.K.","year":"2019","unstructured":"Patil N.K.; Bohannon J.K.; Hernandez A.; Patil T.K.; Sherwood E.R.; Regulation of leukocyte function by citric acid cycle intermediates. J Leukoc Biol  2019,106(1),105-117","journal-title":"J Leukoc Biol"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jnc.15206","volume":"158","author":"Kaushik D.K.","year":"2021","unstructured":"Kaushik D.K.; Yong V.W.; Metabolic needs of brain\u2010infiltrating leukocytes and microglia in multiple sclerosis. J Neurochem  2021,158(1),14-24","journal-title":"J Neurochem"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/BJ20111275","volume":"438","author":"Infantino V.","year":"2011","unstructured":"Infantino V.; Convertini P.; Cucci L.; Panaro M.A.; Di Noia M.A.; Calvello R.; Palmieri F.; Iacobazzi V.; The mitochondrial citrate carrier: A new player in inflammation. Biochem J  2011,438(3),433-436","journal-title":"Biochem J"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"1006512","DOI":"10.1371\/journal.pgen.1006512","volume":"12","author":"Weger B.D.","year":"2016","unstructured":"Weger B.D.; Weger M.; G\u00f6rling B.; Schink A.; Gobet C.; Keime C.; Poschet G.; Jost B.; Krone N.; Hell R.; Gachon F.; Luy B.; Dickmeis T.; Extensive regulation of diurnal transcription and metabolism by glucocorticoids. PLoS Genet  2016,12(12),1006512","journal-title":"PLoS Genet"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"2123265119","DOI":"10.1073\/pnas.2123265119","volume":"119","author":"Zahoor I.","year":"2022","unstructured":"Zahoor I.; Suhail H.; Datta I.; Ahmed M.E.; Poisson L.M.; Waters J.; Rashid F.; Bin R.; Singh J.; Cerghet M.; Kumar A.; Hoda M.N.; Rattan R.; Mangalam A.K.; Giri S.; Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target. Proc Natl Acad Sci USA  2022,119(25),2123265119","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"146589","DOI":"10.1016\/j.brainres.2019.146589","volume":"1732","author":"Sylvestre D.A.","year":"2020","unstructured":"Sylvestre D.A.; Slupsky C.M.; Aviv R.I.; Swardfager W.; Taha A.Y.; Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain. Brain Res  2020,1732,146589","journal-title":"Brain Res"},{"key":"ref=235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24966\/HE-9640\/100005","volume":"1","author":"Costello L.C.","year":"2016","unstructured":"Costello L.C.; Franklin R.B.; Plasma citrate homeostasis: How it is regulated; and its physiological and clinical implications. An important, but neglected, relationship in medicine. J Hum Endocrinol  2016,1(1),1-5","journal-title":"J Hum Endocrinol"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/metabo9100201","volume":"9","author":"Macias S.","year":"2019","unstructured":"Macias S.; Kirma J.; Yilmaz A.; Moore S.E.; McKinley M.C.; McKeown P.P.; Woodside J.V.; Graham S.F.; Green B.D.; Application of 1H-NMR metabolomics for the discovery of blood plasma biomarkers of a mediterranean diet. Metabolites  2019,9(10),201","journal-title":"Metabolites"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"12588","DOI":"10.1016\/S0021-9258(18)98939-8","volume":"266","author":"Taguchi H.","year":"1991","unstructured":"Taguchi H.; Ohta T.; D-lactate dehydrogenase is a member of the D-isomer-specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in Escherichia coli of the D-lactate dehydrogenase gene of Lactobacillus plantarum. J Biol Chem  1991,266(19),12588-12594","journal-title":"J Biol Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0006-291X(92)91157-L","volume":"184","author":"Kochhar S.","year":"1992","unstructured":"Kochhar S.; Hunziker P.E.; Leong-Morgenthaler P.; Hottinger H.; Evolutionary relationship of NAD+-dependent D-lactate dehydrogenase: Comparison of primary structure of 2-hydroxy acid dehydrogenases. Biochem Biophys Res Commun  1992,184(1),60-66","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"100915","DOI":"10.1016\/j.arr.2019.100915","volume":"53","author":"de Bari L.","year":"2019","unstructured":"de Bari L.; Atlante A.; Armeni T.; Kalapos M.P.; Synthesis and metabolism of methylglyoxal, S-D-lactoylglutathione and D-lactate in cancer and Alzheimer\u2019s disease. Exploring the crossroad of eternal youth and premature aging. Ageing Res Rev  2019,53,100915","journal-title":"Ageing Res Rev"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"808799","DOI":"10.3389\/fimmu.2021.808799","volume":"12","author":"Manosalva C.","year":"2022","unstructured":"Manosalva C.; Quiroga J.; Hidalgo A.I.; Alarc\u00f3n P.; Ansoleaga N.; Hidalgo M.A.; Burgos R.A.; Role of lactate in inflammatory processes: Friend or foe. Front Immunol  2022,12,808799","journal-title":"Front Immunol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"Colegio O.R.","year":"2014","unstructured":"Colegio O.R.; Chu N.Q.; Szabo A.L.; Chu T.; Rhebergen A.M.; Jairam V.; Cyrus N.; Brokowski C.E.; Eisenbarth S.C.; Phillips G.M.; Cline G.W.; Phillips A.J.; Medzhitov R.; Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature  2014,513(7519),559-563","journal-title":"Nature"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.biotechadv.2018.09.003","volume":"36","author":"de Melo Pereira G.V.","year":"2018","unstructured":"de Melo Pereira G.V.; de Oliveira Coelho B.; Magalh\u00e3es, J\u00fanior, A.I.; Thomaz-Soccol, V.; Soccol, C.R. How to select a probiotic? A review and update of methods and criteria. Biotechnol Adv  2018,36(8),2060-2076","journal-title":"Biotechnol Adv"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"Llibre A.","year":"2025","unstructured":"Llibre A.; Kucuk S.; Gope A.; Certo M.; Mauro C.; Lactate: A key regulator of the immune response. Immunity  2025,58(3),535-554","journal-title":"Immunity"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12974-018-1281-7","volume":"15","author":"Rubio-Araiz A.","year":"2018","unstructured":"Rubio-Araiz A.; Finucane O.M.; Keogh S.; Lynch M.A.; Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of \u03b2-amyloid. J Neuroinflammation  2018,15(1),247","journal-title":"J Neuroinflammation"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.febslet.2013.01.067","volume":"587","author":"Voloboueva L.A.","year":"2013","unstructured":"Voloboueva L.A.; Emery J.F.; Sun X.; Giffard R.G.; Inflammatory response of microglial BV\u20102 cells includes a glycolytic shift and is modulated by mitochondrial glucose\u2010regulated protein 75\/mortalin. FEBS Lett  2013,587(6),756-762","journal-title":"FEBS Lett"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","volume":"30","author":"Pucino V.","year":"2019","unstructured":"Pucino V.; Certo M.; Bulusu V.; Cucchi D.; Goldmann K.; Pontarini E.; Haas R.; Smith J.; Headland S.E.; Blighe K.; Ruscica M.; Humby F.; Lewis M.J.; Kamphorst J.J.; Bombardieri M.; Pitzalis C.; Mauro C.; Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring. Cell Metab  2019,30(6),1055-1074.e8","journal-title":"Cell Metab"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"1002202","DOI":"10.1371\/journal.pbio.1002202","volume":"13","author":"Haas R.","year":"2015","unstructured":"Haas R.; Smith J.; Rocher-Ros V.; Nadkarni S.; Montero-Melendez T.; D\u2019Acquisto F.; Bland E.J.; Bombardieri M.; Pitzalis C.; Perretti M.; Marelli-Berg F.M.; Mauro C.; Lactate regulates metabolic and pro-inflammatory circuits in control of t cell migration and effector functions. PLoS Biol  2015,13(7),1002202","journal-title":"PLoS Biol"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"Angelin A.","year":"2017","unstructured":"Angelin A.; Gil-de-G\u00f3mez L.; Dahiya S.; Jiao J.; Guo L.; Levine M.H.; Wang Z.; Quinn W.J.; Kopinski P.K.; Wang L.; Akimova T.; Liu Y.; Bhatti T.R.; Han R.; Laskin B.L.; Baur J.A.; Blair I.A.; Wallace D.C.; Hancock W.W.; Beier U.H.; Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab  2017,25(6),1282-1293.e7","journal-title":"Cell Metab"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1038\/s41467-024-51207-x","volume":"15","author":"Romero M.","year":"2024","unstructured":"Romero M.; Miller K.; Gelsomini A.; Garcia D.; Li K.; Suresh D.; Frasca D.; Immunometabolic effects of lactate on humoral immunity in healthy individuals of different ages. Nat Commun  2024,15(1),7515","journal-title":"Nat Commun"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","volume":"620","author":"Sanmarco L.M.","year":"2023","unstructured":"Sanmarco L.M.; Rone J.M.; Polonio C.M.; Fernandez Lahore G.; Giovannoni F.; Ferrara K.; Gutierrez-Vazquez C.; Li N.; Sokolovska A.; Plasencia A.; Faust Akl C.; Nanda P.; Heck E.S.; Li Z.; Lee H.G.; Chao C.C.; Rejano-Gordillo C.M.; Fonseca-Castro P.H.; Illouz T.; Linnerbauer M.; Kenison J.E.; Barilla R.M.; Farrenkopf D.; Stevens N.A.; Piester G.; Chung E.N.; Dailey L.; Kuchroo V.K.; Hava D.; Wheeler M.A.; Clish C.; Nowarski R.; Balsa E.; Lora J.M.; Quintana F.J.; Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells. Nature  2023,620(7975),881-889","journal-title":"Nature"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1172\/JCI124012","volume":"129","author":"Kaushik D.K.","year":"2019","unstructured":"Kaushik D.K.; Bhattacharya A.; Mirzaei R.; Rawji K.S.; Ahn Y.; Rho J.M.; Yong V.W.; Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis. J Clin Invest  2019,129(8),3277-3292","journal-title":"J Clin Invest"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1371\/journal.pone.0000595","volume":"2","author":"Lutz N.W.","year":"2007","unstructured":"Lutz N.W.; Viola A.; Malikova I.; Confort-Gouny S.; Audoin B.; Ranjeva J.P.; Pelletier J.; Cozzone P.J.; Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid. PLoS One  2007,2(7),595","journal-title":"PLoS One"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/01616412.2021.1893567","volume":"43","author":"Esmael A.","year":"2021","unstructured":"Esmael A.; Talaat M.; Egila H.; Eltoukhy K.; Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings. Neurol Res  2021,43(7),582-590","journal-title":"Neurol Res"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44192-022-00011-4","volume":"2","author":"Chen X.","year":"2022","unstructured":"Chen X.; Zhang Y.; Wang H.; Liu L.; Li W.; Xie P.; The regulatory effects of lactic acid on neuropsychiatric disorders. Discov Ment Health  2022,2(1),8","journal-title":"Discov Ment Health"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.3390\/nu13124284","volume":"13","author":"Amato A.","year":"2021","unstructured":"Amato A.; Ragonese P.; Ingoglia S.; Schiera G.; Schir\u00f2 G.; Di Liegro C.M.; Salemi G.; Di Liegro I.; Proia P.; Lactate threshold training program on patients with multiple sclerosis: A multidisciplinary approach. Nutrients  2021,13(12),4284","journal-title":"Nutrients"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"103454","DOI":"10.1016\/j.msard.2021.103454","volume":"57","author":"Cerexhe L.","year":"2022","unstructured":"Cerexhe L.; Easton C.; Macdonald E.; Renfrew L.; Sculthorpe N.; Blood lactate concentrations during rest and exercise in people with multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord  2022,57,103454","journal-title":"Mult Scler Relat Disord"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"58","DOI":"10.23736\/S1973-9087.17.04637-8","volume":"54","author":"Zaenker P.","year":"2018","unstructured":"Zaenker P.; Favret F.; Lonsdorfer E.; Muff G.; de Seze J.; Isner-Horobeti M.E.; High-intensity interval training combined with resistance training improves physiological capacities, strength and quality of life in multiple sclerosis patients: A pilot study. Eur J Phys Rehabil Med  2018,54(1),58-67","journal-title":"Eur J Phys Rehabil Med"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"160463","DOI":"10.1172\/JCI160463","volume":"133","author":"Zeng Y.R.","year":"2023","unstructured":"Zeng Y.R.; Song J.B.; Wang D.; Huang Z.X.; Zhang C.; Sun Y.P.; Shu G.; Xiong Y.; Guan K.L.; Ye D.; Wang P.; The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response. J Clin Invest  2023,133(6),160463","journal-title":"J Clin Invest"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","volume":"34","author":"Runtsch M.C.","year":"2022","unstructured":"Runtsch M.C.; Angiari S.; Hooftman A.; Wadhwa R.; Zhang Y.; Zheng Y.; Spina J.S.; Ruzek M.C.; Argiriadi M.A.; McGettrick A.F.; Mendez R.S.; Zotta A.; Peace C.G.; Walsh A.; Chirillo R.; Hams E.; Fallon P.G.; Jayaraman R.; Dua K.; Brown A.C.; Kim R.Y.; Horvat J.C.; Hansbro P.M.; Wang C.; O\u2019Neill L.A.J.; Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab  2022,34(3),487-501.e8","journal-title":"Cell Metab"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"148548","DOI":"10.1172\/JCI148548","volume":"132","author":"Peace C.G.","year":"2022","unstructured":"Peace C.G.; O\u2019Neill L.A.J.; The role of itaconate in host defense and inflammation. J Clin Invest  2022,132(2),148548","journal-title":"J Clin Invest"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","volume":"19","author":"O\u2019Neill L.A.J.","year":"2019","unstructured":"O\u2019Neill L.A.J.; Artyomov M.N.; Itaconate: The poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol  2019,19(5),273-281","journal-title":"Nat Rev Immunol"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"Mills E.L.","year":"2018","unstructured":"Mills E.L.; Ryan D.G.; Prag H.A.; Dikovskaya D.; Menon D.; Zaslona Z.; Jedrychowski M.P.; Costa A.S.H.; Higgins M.; Hams E.; Szpyt J.; Runtsch M.C.; King M.S.; McGouran J.F.; Fischer R.; Kessler B.M.; McGettrick A.F.; Hughes M.M.; Carroll R.G.; Booty L.M.; Knatko E.V.; Meakin P.J.; Ashford M.L.J.; Modis L.K.; Brunori G.; S\u00e9vin D.C.; Fallon P.G.; Caldwell S.T.; Kunji E.R.S.; Chouchani E.T.; Frezza C.; Dinkova-Kostova A.T.; Hartley R.C.; Murphy M.P.; O\u2019Neill L.A.; Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature  2018,556(7699),113-117","journal-title":"Nature"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"Auger J.P.","year":"2024","unstructured":"Auger J.P.; Zimmermann M.; Faas M.; Stifel U.; Chambers D.; Krishnacoumar B.; Taudte R.V.; Grund C.; Erdmann G.; Scholtysek C.; Uderhardt S.; Ben Brahim O.; Pascual Mat\u00e9 M.; Stoll C.; B\u00f6ttcher M.; Palumbo-Zerr K.; Mangan M.S.J.; Dzamukova M.; Kieler M.; Hofmann M.; Bl\u00fcml S.; Schabbauer G.; Mougiakakos D.; Sonnewald U.; Hartmann F.; Simon D.; Kleyer A.; Gr\u00fcneboom A.; Finotto S.; Latz E.; Hofmann J.; Schett G.; Tuckermann J.; Kr\u00f6nke G.; Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature  2024,629(8010),184-192","journal-title":"Nature"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"1010361","DOI":"10.1371\/journal.ppat.1010361","volume":"18","author":"Coelho C.","year":"2022","unstructured":"Coelho C.; Itaconate or how I learned to stop avoiding the study of immunometabolism. PLoS Pathog  2022,18(3),1010361","journal-title":"PLoS Pathog"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmet.2019.11.019","volume":"32","author":"Cordes T.","year":"2020","unstructured":"Cordes T.; Lucas A.; Divakaruni A.S.; Murphy A.N.; Cabrales P.; Metallo C.M.; Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab  2020,32,122-135","journal-title":"Mol Metab"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12974-020-01768-7","volume":"17","author":"Kuo P.C.","year":"2020","unstructured":"Kuo P.C.; Weng W.T.; Scofield B.A.; Paraiso H.C.; Brown D.A.; Wang P.Y.; Yu I.C.; Yen J.H.; Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis. J Neuroinflammation  2020,17(1),138","journal-title":"J Neuroinflammation"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10753-024-02050-1","volume":"48","author":"Zhao N.","year":"2024","unstructured":"Zhao N.; Yi M.; Zhang L.J.; Zhang Q.X.; Yang L.; 4-octyl itaconate attenuates neuroinflammation in experimental autoimmune encephalomyelitis via regulating microglia. Inflammation  2024,48(1),151-164","journal-title":"Inflammation"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/imm.13454","volume":"165","author":"Hoyle C.","year":"2022","unstructured":"Hoyle C.; Green J.P.; Allan S.M.; Brough D.; Lemarchand E.; Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages. Immunology  2022,165(4),460-480","journal-title":"Immunology"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"101966","DOI":"10.1016\/j.mito.2024.101966","volume":"79","author":"Sangineto M.","year":"2024","unstructured":"Sangineto M.; Ciarnelli M.; Moola A.; Naik Bukke V.; Cassano T.; Villani R.; Romano A.D.; Di Gioia G.; Avolio C.; Serviddio G.; Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line. Mitochondrion  2024,79,101966","journal-title":"Mitochondrion"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"114142","DOI":"10.1016\/j.celrep.2024.114142","volume":"43","author":"Yu Z.","year":"2024","unstructured":"Yu Z.; Li X.; Quan Y.; Chen J.; Liu J.; Zheng N.; Liu S.; Wang Y.; Liu W.; Qiu C.; Wang Y.; Zheng R.; Qin J.; Itaconate alleviates diet-induced obesity via activation of brown adipocyte thermogenesis. Cell Rep  2024,43(5),114142","journal-title":"Cell Rep"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40168-023-01471-8","volume":"11","author":"Pan W.","year":"2023","unstructured":"Pan W.; Zhao J.; Wu J.; Xu D.; Meng X.; Jiang P.; Shi H.; Ge X.; Yang X.; Hu M.; Zhang P.; Tang R.; Nagaratnam N.; Zheng K.; Huang X.F.; Yu Y.; Dimethyl itaconate ameliorates cognitive impairment induced by a high-fat diet via the gut-brain axis in mice. Microbiome  2023,11(1),30","journal-title":"Microbiome"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-024-06483-2","volume":"15","author":"Eberhart T.","year":"2024","unstructured":"Eberhart T.; Stanley F.U.; Ricci L.; Chirico T.; Ferrarese R.; Sisti S.; Scagliola A.; Baj A.; Badurek S.; Sommer A.; Culp-Hill R.; Dzieciatkowska M.; Shokry E.; Sumpton D.; D\u2019Alessandro A.; Clementi N.; Mancini N.; Cardaci S.; ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota. Cell Death Dis  2024,15(2),105","journal-title":"Cell Death Dis"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/pr5007894","volume":"14","author":"V\u00e1zquez-Fresno R.","year":"2015","unstructured":"V\u00e1zquez-Fresno R.; Llorach R.; Urpi-Sarda M.; Lupianez-Barbero A.; Estruch R.; Corella D.; Fit\u00f3 M.; Ar\u00f3s F.; Ruiz-Canela M.; Salas-Salvad\u00f3 J.; Andres-Lacueva C.; Metabolomic pattern analysis after mediterranean diet intervention in a nondiabetic population: A 1- and 3-year follow-up in the PREDIMED study. J Proteome Res  2015,14(1),531-540","journal-title":"J Proteome Res"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"8272","DOI":"10.3390\/ijms23158272","volume":"23","author":"Schiweck C.","year":"2022","unstructured":"Schiweck C.; Edwin Thanarajah S.; Aichholzer M.; Matura S.; Reif A.; Vrieze E.; Weigert A.; Visekruna A.; Regulation of CD4+ and CD8+ T cell biology by short-chain fatty acids and its relevance for autoimmune pathology. Int J Mol Sci  2022,23(15),8272","journal-title":"Int J Mol Sci"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"Luu M.","year":"2019","unstructured":"Luu M.; Pautz S.; Kohl V.; Singh R.; Romero R.; Lucas S.; Hofmann J.; Raifer H.; Vachharajani N.; Carrascosa L.C.; Lamp B.; Nist A.; Stiewe T.; Shaul Y.; Adhikary T.; Zaiss M.M.; Lauth M.; Steinhoff U.; Visekruna A.; The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun  2019,10(1),760","journal-title":"Nat Commun"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1079\/PNS2002207","volume":"62","author":"Macfarlane S.","year":"2003","unstructured":"Macfarlane S.; Macfarlane G.T.; Regulation of short-chain fatty acid production. Proc Nutr Soc  2003,62(1),67-72","journal-title":"Proc Nutr Soc"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"25481","DOI":"10.1074\/jbc.M301403200","volume":"278","author":"Le Poul E.","year":"2003","unstructured":"Le Poul E.; Loison C.; Struyf S.; Springael J.Y.; Lannoy V.; Decobecq M.E.; Brezillon S.; Dupriez V.; Vassart G.; Van Damme J.; Parmentier M.; Detheux M.; Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem  2003,278(28),25481-25489","journal-title":"J Biol Chem"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"785833","DOI":"10.3389\/fcimb.2021.785833","volume":"11","author":"Schlatterer K.","year":"2021","unstructured":"Schlatterer K.; Peschel A.; Kretschmer D.; Short-chain fatty acid and ffar2 activation \u2013 a new option for treating infections? Front Cell Infect Microbiol  2021,11,785833","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2016.01.021","volume":"110-111","author":"Moniri N.H.","year":"2016","unstructured":"Moniri N.H.; Free-fatty acid receptor-4 (GPR120): Cellular and molecular function and its role in metabolic disorders. Biochem Pharmacol  2016,110-111,1-15","journal-title":"Biochem Pharmacol"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","volume":"40","author":"Thorburn A.N.","year":"2014","unstructured":"Thorburn A.N.; Macia L.; Mackay C.R.; Diet, metabolites, and \u201cwestern-lifestyle\u201d inflammatory diseases. Immunity  2014,40(6),833-842","journal-title":"Immunity"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"He Y.","year":"2021","unstructured":"He Y.; Fu L.; Li Y.; Wang W.; Gong M.; Zhang J.; Dong X.; Huang J.; Wang Q.; Mackay C.R.; Fu Y.X.; Chen Y.; Guo X.; Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab  2021,33(5),988-1000.e7","journal-title":"Cell Metab"},{"key":"ref=282","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s42255-024-01037-4","volume":"6","author":"Wang J.","year":"2024","unstructured":"Wang J.; Yang Y.; Shao F.; Meng Y.; Guo D.; He J.; Lu Z.; Acetate reprogrammes tumour metabolism and promotes PD-L1 expression and immune evasion by upregulating c-Myc. Nat Metab  2024,6(5),914-932","journal-title":"Nat Metab"},{"key":"ref=283","doi-asserted-by":"publisher","first-page":"11745","DOI":"10.1038\/s41598-017-12163-3","volume":"7","author":"Nakamura Y.K.","year":"2017","unstructured":"Nakamura Y.K.; Janowitz C.; Metea C.; Asquith M.; Karstens L.; Rosenbaum J.T.; Lin P.; Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep  2017,7(1),11745","journal-title":"Sci Rep"},{"key":"ref=284","doi-asserted-by":"publisher","first-page":"106335","DOI":"10.1371\/journal.pone.0106335","volume":"9","author":"Nouri M.","year":"2014","unstructured":"Nouri M.; Bredberg A.; Westr\u00f6m B.; Lavasani S.; Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS One  2014,9(9),106335","journal-title":"PLoS One"},{"key":"ref=285","doi-asserted-by":"publisher","first-page":"701626","DOI":"10.3389\/fimmu.2021.701626","volume":"12","author":"Haase S.","year":"2021","unstructured":"Haase S.; M\u00e4urer J.; Duscha A.; Lee D.H.; Balogh A.; Gold R.; M\u00fcller D.N.; Haghikia A.; Linker R.A.; Propionic acid rescues high-fat diet enhanced immunopathology in autoimmunity via effects on th17 responses. Front Immunol  2021,12,701626","journal-title":"Front Immunol"},{"key":"ref=286","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/s41598-022-27086-x","volume":"13","author":"Caetano-Silva M.E.","year":"2023","unstructured":"Caetano-Silva M.E.; Rund L.; Hutchinson N.T.; Woods J.A.; Steelman A.J.; Johnson R.W.; Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci Rep  2023,13(1),2819","journal-title":"Sci Rep"},{"key":"ref=287","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1038\/s41598-021-84881-8","volume":"11","author":"Trend S.","year":"2021","unstructured":"Trend S.; Leffler J.; Jones A.P.; Cha L.; Gorman S.; Brown D.A.; Breit S.N.; Kermode A.G.; French M.A.; Ward N.C.; Hart P.H.; Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis. Sci Rep  2021,11(1),5244","journal-title":"Sci Rep"},{"key":"ref=288","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1038\/s41598-019-45311-y","volume":"9","author":"Park J.","year":"2019","unstructured":"Park J.; Wang Q.; Wu Q.; Mao-Draayer Y.; Kim C.H.; Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation. Sci Rep  2019,9(1),8837","journal-title":"Sci Rep"},{"key":"ref=289","doi-asserted-by":"publisher","first-page":"1123841","DOI":"10.3389\/fimmu.2023.1123841","volume":"14","author":"Koda S.","year":"2023","unstructured":"Koda S.; Hu J.; Ju X.; Sun G.; Shao S.; Tang R.X.; Zheng K.Y.; Yan J.; The role of glutamate receptors in the regulation of the tumor microenvironment. Front Immunol  2023,14,1123841","journal-title":"Front Immunol"},{"key":"ref=290","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1073\/pnas.1112495109","volume":"109","author":"Cassago A.","year":"2012","unstructured":"Cassago A.; Ferreira A.P.S.; Ferreira I.M.; Fornezari C.; Gomes E.R.M.; Greene K.S.; Pereira H.M.; Garratt R.C.; Dias S.M.G.; Ambrosio A.L.B.; Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci USA  2012,109(4),1092-1097","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=291","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1073\/pnas.1714717115","volume":"115","author":"Kono M.","year":"2018","unstructured":"Kono M.; Yoshida N.; Maeda K.; Tsokos G.C.; Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells. Proc Natl Acad Sci USA  2018,115(10),2478-2483","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=292","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"Wang R.","year":"2011","unstructured":"Wang R.; Dillon C.P.; Shi L.Z.; Milasta S.; Carter R.; Finkelstein D.; McCormick L.L.; Fitzgerald P.; Chi H.; Munger J.; Green D.R.; The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity  2011,35(6),871-882","journal-title":"Immunity"},{"key":"ref=293","doi-asserted-by":"publisher","first-page":"109911","DOI":"10.1016\/j.celrep.2021.109911","volume":"37","author":"Matias M.I.","year":"2021","unstructured":"Matias M.I.; Yong C.S.; Foroushani A.; Goldsmith C.; Mongellaz C.; Sezgin E.; Levental K.R.; Talebi A.; Perrault J.; Rivi\u00e8re A.; Dehairs J.; Delos O.; Bertand-Michel J.; Portais J.C.; Wong M.; Marie J.C.; Kelekar A.; Kinet S.; Zimmermann V.S.; Levental I.; Yvan-Charvet L.; Swinnen J.V.; Muljo S.A.; Hernandez-Vargas H.; Tardito S.; Taylor N.; Dardalhon V.; Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep  2021,37(5),109911","journal-title":"Cell Rep"},{"key":"ref=294","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3408467","volume":"2018","author":"Liu S.","year":"2018","unstructured":"Liu S.; He L.; Yao K.; The antioxidative function of alpha-ketoglutarate and its applications. BioMed Res Int  2018,2018(1),1-6","journal-title":"BioMed Res Int"},{"key":"ref=295","doi-asserted-by":"publisher","first-page":"91965","DOI":"10.18632\/oncotarget.20555","volume":"8","author":"He L.","year":"2017","unstructured":"He L.; Zhou X.; Huang N.; Li H.; Cui Z.; Tian J.; Jiang Q.; Liu S.; Wu J.; Li T.; Yao K.; Yin Y.; Administration of alpha-ketoglutarate improves epithelial restitution under stress injury in early-weaning piglets. Oncotarget  2017,8(54),91965-91978","journal-title":"Oncotarget"},{"key":"ref=296","doi-asserted-by":"publisher","first-page":"38184","DOI":"10.18632\/oncotarget.17132","volume":"8","author":"Chen S.","year":"2017","unstructured":"Chen S.; Bin P.; Ren W.; Gao W.; Liu G.; Yin J.; Duan J.; Li Y.; Yao K.; Huang R.; Tan B.; Yin Y.; Alpha-ketoglutarate (AKG) lowers body weight and affects intestinal innate immunity through influencing intestinal microbiota. Oncotarget  2017,8(24),38184-38192","journal-title":"Oncotarget"},{"key":"ref=297","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tem.2021.11.003","volume":"33","author":"Gyanwali B.","year":"2022","unstructured":"Gyanwali B.; Lim Z.X.; Soh J.; Lim C.; Guan S.P.; Goh J.; Maier A.B.; Kennedy B.K.; Alpha-Ketoglutarate dietary supplementation to improve health in humans. Trends Endocrinol Metab  2022,33(2),136-146","journal-title":"Trends Endocrinol Metab"},{"key":"ref=298","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1124\/mol.113.087775","volume":"84","author":"Magi S.","year":"2013","unstructured":"Magi S.; Arcangeli S.; Castaldo P.; Nasti A.A.; Berrino L.; Piegari E.; Bernardini R.; Amoroso S.; Lariccia V.; Glutamate-induced ATP synthesis: Relationship between plasma membrane Na+\/Ca2+ exchanger and excitatory amino acid transporters in brain and heart cell models. Mol Pharmacol  2013,84(4),603-614","journal-title":"Mol Pharmacol"},{"key":"ref=299","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0026-0495(89)90136-4","volume":"38","author":"Brand K.","year":"1989","unstructured":"Brand K.; Fekl W.; von Hintzenstern J.; Langer K.; Luppa P.; Schoerner C.; Metabolism of glutamine in lymphocytes. Metabolism  1989,38(8),29-33","journal-title":"Metabolism"},{"key":"ref=300","doi-asserted-by":"publisher","first-page":"113954","DOI":"10.1371\/journal.pone.0113954","volume":"9","author":"Sulkowski G.","year":"2014","unstructured":"Sulkowski G.; D\u0105browska-Bouta B.; Sali\u0144ska E.; Stru\u017cy\u0144ska L.; Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain. PLoS One  2014,9(11),113954","journal-title":"PLoS One"},{"key":"ref=301","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0165-5728(02)00029-2","volume":"125","author":"Ohgoh M.","year":"2002","unstructured":"Ohgoh M.; Hanada T.; Smith T.; Hashimoto T.; Ueno M.; Yamanishi Y.; Watanabe M.; Nishizawa Y.; Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol  2002,125(1-2),170-178","journal-title":"J Neuroimmunol"},{"key":"ref=302","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.3390\/ijms20225671","volume":"20","author":"Malik A.R.","year":"2019","unstructured":"Malik A.R.; Willnow T.E.; Excitatory amino acid transporters in physiology and disorders of the central nervous system. Int J Mol Sci  2019,20(22),5671","journal-title":"Int J Mol Sci"},{"key":"ref=303","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jneuroim.2007.05.021","volume":"188","author":"Sarchielli P.","year":"2007","unstructured":"Sarchielli P.; Di Filippo M.; Candeliere A.; Chiasserini D.; Mattioni A.; Tenaglia S.; Bonucci M.; Calabresi P.; Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol  2007,188(1-2),146-158","journal-title":"J Neuroimmunol"},{"key":"ref=304","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.2183","volume":"16","author":"Fallarino F.","year":"2010","unstructured":"Fallarino F.; Volpi C.; Fazio F.; Notartomaso S.; Vacca C.; Busceti C.; Bicciato S.; Battaglia G.; Bruno V.; Puccetti P.; Fioretti M.C.; Nicoletti F.; Grohmann U.; Di Marco R.; Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat Med  2010,16(8),897-902","journal-title":"Nat Med"},{"key":"ref=305","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/ars.2016.6715","volume":"26","author":"Palmieri E.M.","year":"2017","unstructured":"Palmieri E.M.; Menga A.; Lebrun A.; Hooper D.C.; Butterfield D.A.; Mazzone M.; Castegna A.; Blockade of glutamine synthetase enhances inflammatory response in microglial cells. Antioxid Redox Signal  2017,26(8),351-363","journal-title":"Antioxid Redox Signal"},{"key":"ref=306","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1212\/NXI.0000000000000609","volume":"6","author":"Hollinger K.R.","year":"2019","unstructured":"Hollinger K.R.; Smith M.D.; Kirby L.A.; Prchalova E.; Alt J.; Rais R.; Calabresi P.A.; Slusher B.S.; Glutamine antagonism attenuates physical and cognitive deficits in a model of MS. Neurol Neuroimmunol Neuroinflamm  2019,6(6),609","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref=307","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.41019","volume":"71","author":"Kono M.","year":"2019","unstructured":"Kono M.; Yoshida N.; Maeda K.; Su\u00e1rez-Fueyo A.; Kyttaris V.C.; Tsokos G.C.; Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus\u2010like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis. Arthritis Rheumatol  2019,71(11),1869-1878","journal-title":"Arthritis Rheumatol"},{"key":"ref=308","doi-asserted-by":"publisher","first-page":"fcac262","DOI":"10.1093\/braincomms\/fcac262","volume":"4","author":"Kumar A.","year":"2022","unstructured":"Kumar A.; Sharma M.; Su Y.; Singh S.; Hsu F.C.; Neth B.J.; Register T.C.; Blennow K.; Zetterberg H.; Craft S.; Deep G.; Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment. Brain Commun  2022,4(6),fcac262","journal-title":"Brain Commun"},{"key":"ref=309","doi-asserted-by":"publisher","first-page":"9320802","DOI":"10.1155\/2017\/9320802","volume":"2017","author":"Al Gawwam G.","year":"2017","unstructured":"Al Gawwam G.; Sharquie I.K.; Serum glutamate is a predictor for the diagnosis of multiple sclerosis. Sci World J  2017,2017,9320802","journal-title":"Sci World J"},{"key":"ref=310","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archneur.60.8.1082","volume":"60","author":"Sarchielli P.","year":"2003","unstructured":"Sarchielli P.; Greco L.; Floridi A.; Floridi A.; Gallai V.; Excitatory amino acids and multiple sclerosis: Evidence from cerebrospinal fluid. Arch Neurol  2003,60(8),1082-1088","journal-title":"Arch Neurol"},{"key":"ref=311","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1093\/jn\/nxaa273","volume":"150","author":"Papandreou C.","year":"2020","unstructured":"Papandreou C.; Hern\u00e1ndez-Alonso P.; Bull\u00f3 M.; Ruiz-Canela M.; Li J.; Guasch-Ferr\u00e9 M.; Toledo E.; Clish C.; Corella D.; Estruch R.; Cof\u00e1n M.; Fit\u00f3 M.; Razquin C.; Ar\u00f3s F.; Fiol M.; Santos-Lozano J.M.; Serra-Majem L.; Liang L.; Mart\u00cdnez-Gonz\u00e1lez, M.A.; Hu, F.B.; Salas-Salvad\u00f3, J. High plasma glutamate and a low glutamine-to-glutamate ratio are associated with increased risk of heart failure but not atrial fibrillation in the prevenci\u00f3n con dieta mediterr\u00e1nea (PREDIMED) study. J Nutr  2020,150(11),2882-2889","journal-title":"J Nutr"},{"key":"ref=312","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cmet.2023.04.017","volume":"35","author":"Cheng J.","year":"2023","unstructured":"Cheng J.; Yan J.; Liu Y.; Shi J.; Wang H.; Zhou H.; Zhou Y.; Zhang T.; Zhao L.; Meng X.; Gong H.; Zhang X.; Zhu H.; Jiang P.; Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metab  2023,35(6),961-978.e10","journal-title":"Cell Metab"},{"key":"ref=313","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/8904_2017_65","volume":"40","author":"Ryder B.","year":"2017","unstructured":"Ryder B.; Moore F.; Mitchell A.; Thompson S.; Christodoulou J.; Balasubramaniam S.; Fumarase deficiency: A safe and potentially disease modifying effect of high fat\/low carbohydrate diet. JIMD Rep  2017,40,77-83","journal-title":"JIMD Rep"},{"key":"ref=314","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tcb.2023.10.005","volume":"34","author":"Peace C.G.","year":"2024","unstructured":"Peace C.G.; O\u2019Carroll S.M.; O\u2019Neill L.A.J.; Fumarate hydratase as a metabolic regulator of immunity. Trends Cell Biol  2024,34(6),442-450","journal-title":"Trends Cell Biol"},{"key":"ref=315","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41586-023-05720-6","volume":"615","author":"Hooftman A.","year":"2023","unstructured":"Hooftman A.; Peace C.G.; Ryan D.G.; Day E.A.; Yang M.; McGettrick A.F.; Yin M.; Montano E.N.; Huo L.; Toller-Kawahisa J.E.; Zecchini V.; Ryan T.A.J.; Bolado-Carrancio A.; Casey A.M.; Prag H.A.; Costa A.S.H.; De Los Santos G.; Ishimori M.; Wallace D.J.; Venuturupalli S.; Nikitopoulou E.; Frizzell N.; Johansson C.; Von Kriegsheim A.; Murphy M.P.; Jefferies C.; Frezza C.; O\u2019Neill L.A.J.; Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. Nature  2023,615(7952),490-498","journal-title":"Nature"},{"key":"ref=316","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/acn3.553","volume":"5","author":"Hammer A.","year":"2018","unstructured":"Hammer A.; Waschbisch A.; Kuhbandner K.; Bayas A.; Lee D.H.; Duscha A.; Haghikia A.; Gold R.; Linker R.A.; The NRF 2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. Ann Clin Transl Neurol  2018,5(6),668-676","journal-title":"Ann Clin Transl Neurol"},{"key":"ref=317","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"P\u00e5lsson-McDermott E.M.","year":"2020","unstructured":"P\u00e5lsson-McDermott E.M.; O\u2019Neill L.A.J.; Targeting immunometabolism as an anti-inflammatory strategy. Cell Res  2020,30(4),300-314","journal-title":"Cell Res"},{"key":"ref=318","doi-asserted-by":"publisher","first-page":"1391949","DOI":"10.3389\/fimmu.2024.1391949","volume":"15","author":"Lima A.D.R.","year":"2024","unstructured":"Lima A.D.R.; Ferrari B.B.; Pradella F.; Carvalho R.M.; Rivero S.L.S.; Quintiliano R.P.S.; Souza M.A.; Brunetti N.S.; Marques A.M.; Santos I.P.; Farias A.S.; Oliveira E.C.; Santos L.M.B.; Dimethyl fumarate modulates the regulatory T cell response in the mesenteric lymph nodes of mice with experimental autoimmune encephalomyelitis. Front Immunol  2024,15,1391949","journal-title":"Front Immunol"},{"key":"ref=319","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1126\/science.aan4665","volume":"360","author":"Kornberg M.D.","year":"2018","unstructured":"Kornberg M.D.; Bhargava P.; Kim P.M.; Putluri V.; Snowman A.M.; Putluri N.; Calabresi P.A.; Snyder S.H.; Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity. Science  2018,360(6387),449-453","journal-title":"Science"},{"key":"ref=320","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/13524585211060686","volume":"28","author":"Sarkar P.","year":"2022","unstructured":"Sarkar P.; Redondo J.; Hares K.; Bailey S.; Georgievskaya A.; Heesom K.; Kemp K.C.; Scolding N.J.; Rice C.M.; Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection. Mult Scler  2022,28(8),1179-1188","journal-title":"Mult Scler"},{"key":"ref=321","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.8456305","volume":"259","author":"Obeid L.M.","year":"1993","unstructured":"Obeid L.M.; Linardic C.M.; Karolak L.A.; Hannun Y.A.; Programmed cell death induced by ceramide. Science  1993,259(5102),1769-1771","journal-title":"Science"},{"key":"ref=322","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","volume":"20","author":"Kitatani K.","year":"2008","unstructured":"Kitatani K.; Idkowiak-Baldys J.; Hannun Y.A.; The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal  2008,20(6),1010-1018","journal-title":"Cell Signal"},{"key":"ref=323","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/nu15010229","volume":"15","author":"Alexandropoulou I.","year":"2023","unstructured":"Alexandropoulou I.; Grammatikopoulou M.G.; Gkouskou K.K.; Pritsa A.A.; Vassilakou T.; Rigopoulou E.; Lindqvist H.M.; Bogdanos D.P.; Ceramides in autoimmune rheumatic diseases: Existing evidence and therapeutic considerations for diet as an anticeramide treatment. Nutrients  2023,15(1),229","journal-title":"Nutrients"},{"key":"ref=324","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.bpj.2015.08.040","volume":"109","author":"Maula T.","year":"2015","unstructured":"Maula T.; Al Sazzad M.A.; Slotte J.P.; Influence of hydroxylation, chain length, and chain unsaturation on bilayer properties of ceramides. Biophys J  2015,109(8),1639-1651","journal-title":"Biophys J"},{"key":"ref=325","doi-asserted-by":"publisher","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","volume":"286","author":"Hannun Y.A.","year":"2011","unstructured":"Hannun Y.A.; Obeid L.M.; Many ceramides. J Biol Chem  2011,286(32),27855-27862","journal-title":"J Biol Chem"},{"key":"ref=326","doi-asserted-by":"publisher","first-page":"39898","DOI":"10.1074\/jbc.M112.416552","volume":"287","author":"Taniguchi M.","year":"2012","unstructured":"Taniguchi M.; Kitatani K.; Kondo T.; Hashimoto-Nishimura M.; Asano S.; Hayashi A.; Mitsutake S.; Igarashi Y.; Umehara H.; Takeya H.; Kigawa J.; Okazaki T.; Regulation of autophagy and its associated cell death by \u201csphingolipid rheostat\u201d: Reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. J Biol Chem  2012,287(47),39898-39910","journal-title":"J Biol Chem"},{"key":"ref=327","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","volume":"333","author":"Newton J.","year":"2015","unstructured":"Newton J.; Lima S.; Maceyka M.; Spiegel S.; Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. Exp Cell Res  2015,333(2),195-200","journal-title":"Exp Cell Res"},{"key":"ref=328","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fmolb.2020.00217","volume":"7","author":"De Lira M.N.","year":"2020","unstructured":"De Lira M.N.; Raman S.J.; Schulze A.; Schneider-Schaulies S.; Avota E.; Neutral sphingomyelinase-2 (NSM 2) controls T cell metabolic homeostasis and reprogramming during activation. Front Mol Biosci  2020,7,217","journal-title":"Front Mol Biosci"},{"key":"ref=329","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0961203316686707","volume":"26","author":"Checa A.","year":"2017","unstructured":"Checa A.; Idborg H.; Zandian A.; Sar D.G.; Surowiec I.; Trygg J.; Svenungsson E.; Jakobsson P-J.; Nilsson P.; Gunnarsson I.; Wheelock C.E.; Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: A cross-sectional study. Lupus  2017,26(10),1023-1033","journal-title":"Lupus"},{"key":"ref=330","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s11064-017-2280-2","volume":"42","author":"Miller L.G.","year":"2017","unstructured":"Miller L.G.; Young J.A.; Ray S.K.; Wang G.; Purohit S.; Banik N.L.; Dasgupta S.; Sphingosine toxicity in eae and ms: Evidence for ceramide generation via serine-palmitoyltransferase activation. Neurochem Res  2017,42(10),2755-2768","journal-title":"Neurochem Res"},{"key":"ref=331","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/brain\/awu139","volume":"137","author":"Vidaurre O.G.","year":"2014","unstructured":"Vidaurre O.G.; Haines J.D.; Katz Sand I.; Adula K.P.; Huynh J.L.; McGraw C.A.; Zhang F.; Varghese M.; Sotirchos E.; Bhargava P.; Bandaru V.V.R.; Pasinetti G.; Zhang W.; Inglese M.; Calabresi P.A.; Wu G.; Miller A.E.; Haughey N.J.; Lublin F.D.; Casaccia P.; Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain  2014,137(8),2271-2286","journal-title":"Brain"},{"key":"ref=332","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","volume":"398","author":"McGinley M.P.","year":"2021","unstructured":"McGinley M.P.; Cohen J.A.; Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions. Lancet  2021,398(10306),1184-1194","journal-title":"Lancet"},{"key":"ref=333","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/cells10010034","volume":"10","author":"Gil A.","year":"2020","unstructured":"Gil A.; Mart\u00edn-Monta\u00f1ez E.; Valverde N.; Lara E.; Boraldi F.; Claros S.; Romero-Zerbo S.Y.; Fern\u00e1ndez O.; Pavia J.; Garcia-Fernandez M.; Neuronal metabolism and neuroprotection: Neuroprotective effect of fingolimod on menadione-induced mitochondrial damage. Cells  2020,10(1),34","journal-title":"Cells"},{"key":"ref=334","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40268-020-00316-1","volume":"20","author":"Bascu\u00f1ana P.","year":"2020","unstructured":"Bascu\u00f1ana P.; M\u00f6hle L.; Brackhan M.; Pahnke J.; Fingolimod as a treatment in neurologic disorders beyond multiple sclerosis. Drugs R D  2020,20(3),197-207","journal-title":"Drugs R D"},{"key":"ref=335","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00401-012-1014-4","volume":"124","author":"van Doorn R.","year":"2012","unstructured":"van Doorn R.; Nijland P.G.; Dekker N.; Witte M.E.; Lopes-Pinheiro M.A.; van het Hof B.; Kooij G.; Reijerkerk A.; Dijkstra C.; van van der Valk, P.; van Horssen, J.; de Vries, H.E. Fingolimod attenuates ceramide-induced blood\u2013brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes. Acta Neuropathol  2012,124(3),397-410","journal-title":"Acta Neuropathol"},{"key":"ref=336","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"Kappos L.","year":"2018","unstructured":"Kappos L.; Bar-Or A.; Cree B.A.C.; Fox R.J.; Giovannoni G.; Gold R.; Vermersch P.; Arnold D.L.; Arnould S.; Scherz T.; Wolf C.; Wallstr\u00f6m E.; Dahlke F.; Achiron A.; Achtnichts L.; Agan K.; Akman-Demir G.; Allen A.B.; Antel J.P.; Antiguedad A.R.; Apperson M.; Applebee A.M.; Ayuso G.I.; Baba M.; Bajenaru O.; Balasa R.; Balci B.P.; Barnett M.; Bass A.; Becker V.U.; Bejinariu M.; Bergh F.T.; Bergmann A.; Bernitsas E.; Berthele A.; Bhan V.; Bischof F.; Bjork R.J.; Blevins G.; Boehringer M.; Boerner T.; Bonek R.; Bowen J.D.; Bowling A.; Boyko A.N.; Boz C.; Bracknies V.; Braune S.; Brescia Morra V.; Brochet B.; Brola W.; Brownstone P.K.; Brozman M.; Brunet D.; Buraga I.; Burnett M.; Buttmann M.; Butzkueven H.; Cahill J.; Calkwood J.C.; Camu W.; Cascione M.; Castelnovo G.; Centonze D.; Cerqueira J.; Chan A.; Cimprichova A.; Cohan S.; Comi G.; Conway J.; Cooper J.A.; Corboy J.; Correale J.; Costell B.; Cottrell D.A.; Coyle P.K.; Craner M.; Cui L.; Cunha L.; Czlonkowska A.; da Silva A.M.; de Sa J.; de Seze J.; Debouverie M.; Debruyne J.; Decoo D.; Defer G.; Derfuss T.; Deri N.H.; Dihenia B.; Dioszeghy P.; Donath V.; Dubois B.; Duddy M.; Duquette P.; Edan G.; Efendi H.; Elias S.; Emrich P.J.; Estruch B.C.; Evdoshenko E.P.; Faiss J.; Fedyanin A.S.; Feneberg W.; Fermont J.; Fernandez O.F.; Ferrer F.C.; Fink K.; Ford H.; Ford C.; Francia A.; Freedman M.; Frishberg B.; Galgani S.; Garmany G.P.; Gehring K.; Gitt J.; Gobbi C.; Goldstick L.P.; Gonzalez R.A.; Grandmaison F.; Grigoriadis N.; Grigorova O.; Grimaldi L.M.E.; Gross J.; Gross-Paju K.; Gudesblatt M.; Guillaume D.; Haas J.; Hancinova V.; Hancu A.; Hardiman O.; Harmjanz A.; Heidenreich F.R.; Hengstman G.J.D.; Herbert J.; Herring M.; Hodgkinson S.; Hoffmann O.M.; Hofmann W.E.; Honeycutt W.D.; Hua L.H.; Huang D.; Huang Y.; Huang D.R.; Hupperts R.; Imre P.; Jacobs A.K.; Jakab G.; Jasinska E.; Kaida K.; Kalnina J.; Kaprelyan A.; Karelis G.; Karussis D.; Katz A.; Khabirov F.A.; Khatri B.; Kimura T.; Kister I.; Kizlaitiene R.; Klimova E.; Koehler J.; Komatineni A.; Kornhuber A.; Kovacs K.; Koves A.; Kozubski W.; Krastev G.; Krupp L.B.; Kurca E.; Lassek C.; Laureys G.; Lee L.; Lensch E.; Leutmezer F.; Li H.; Linker R.A.; Linnebank M.; Liskova P.; Llanera C.; Lu J.; Lutterotti A.; Lycke J.; Macdonell R.; Maciejowski M.; Maeurer M.; Magzhanov R.V.; Maida E-M.; Malciene L.; Mao-Draayer Y.; Marfia G.A.; Markowitz C.; Mastorodimos V.; Matyas K.; Meca-Lallana J.; Merino J.A.G.; Mihetiu I.G.; Milanov I.; Miller A.E.; Millers A.; Mirabella M.; Mizuno M.; Montalban X.; Montoya L.; Mori M.; Mueller S.; Nakahara J.; Nakatsuji Y.; Newsome S.; Nicholas R.; Nielsen A.S.; Nikfekr E.; Nocentini U.; Nohara C.; Nomura K.; Odinak M.M.; Olsson T.; van Oosten B.W.; Oreja-Guevara C.; Oschmann P.; Overell J.; Pachner A.; Panczel G.; Pandolfo M.; Papeix C.; Patrucco L.; Pelletier J.; Piedrabuena R.; Pless M.; Polzer U.; Pozsegovits K.; Rastenyte D.; Rauer S.; Reifschneider G.; Rey R.; Rizvi S.A.; Robertson D.; Rodriguez J.M.; Rog D.; Roshanisefat H.; Rowe V.; Rozsa C.; Rubin S.; Rusek S.; Sacc\u00e0 F.; Saida T.; Salgado A.V.; Sanchez V.E.F.; Sanders K.; Satori M.; Sazonov D.V.; Scarpini E.A.; Schlegel E.; Schluep M.; Schmidt S.; Scholz E.; Schrijver H.M.; Schwab M.; Schwartz R.; Scott J.; Selmaj K.; Shafer S.; Sharrack B.; Shchukin I.A.; Shimizu Y.; Shotekov P.; Siever A.; Sigel K-O.; Silliman S.; Simo M.; Simu M.; Sinay V.; Siquier A.E.; Siva A.; Skoda O.; Solomon A.; Stangel M.; Stefoski D.; Steingo B.; Stolyarov I.D.; Stourac P.; Strassburger-Krogias K.; Strauss E.; Stuve O.; Tarnev I.; Tavernarakis A.; Tello C.R.; Terzi M.; Ticha V.; Ticmeanu M.; Tiel-Wilck K.; Toomsoo T.; Tubridy N.; Tullman M.J.; Tumani H.; Turcani P.; Turner B.; Uccelli A.; Urtaza F.J.O.; Vachova M.; Valikovics A.; Walter S.; Van Wijmeersch B.; Vanopdenbosch L.; Weber J.R.; Weiss S.; Weissert R.; Vermersch P.; West T.; Wiendl H.; Wiertlewski S.; Wildemann B.; Willekens B.; Visser L.H.; Vorobeychik G.; Xu X.; Yamamura T.; Yang Y.N.; Yelamos S.M.; Yeung M.; Zacharias A.; Zelkowitz M.; Zettl U.; Zhang M.; Zhou H.; Zieman U.; Ziemssen T.; Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study. Lancet  2018,391(10127),1263-1273","journal-title":"Lancet"},{"key":"ref=337","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamaneurol.2021.0405","volume":"78","author":"Kappos L.","year":"2021","unstructured":"Kappos L.; Fox R.J.; Burcklen M.; Freedman M.S.; Havrdov\u00e1 E.K.; Hennessy B.; Hohlfeld R.; Lublin F.; Montalban X.; Pozzilli C.; Scherz T.; D\u2019Ambrosio D.; Linscheid P.; Vaclavkova A.; Pirozek-Lawniczek M.; Kracker H.; Sprenger T.; Ponesimod compared with teriflunomide in patients with relapsing multiple sclerosis in the active-comparator phase 3 OPTIMUM study. JAMA Neurol  2021,78(5),558-567","journal-title":"JAMA Neurol"},{"key":"ref=338","doi-asserted-by":"publisher","first-page":"635995","DOI":"10.3389\/fendo.2021.635995","volume":"12","author":"Juchnicka I.","year":"2021","unstructured":"Juchnicka I.; Ku\u017amicki M.; Szamatowicz J.; Ceramides and sphingosino-1-phosphate in obesity. Front Endocrinol  2021,12,635995","journal-title":"Front Endocrinol"},{"key":"ref=339","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","volume":"135","author":"Wang D.D.","year":"2017","unstructured":"Wang D.D.; Toledo E.; Hruby A.; Rosner B.A.; Willett W.C.; Sun Q.; Razquin C.; Zheng Y.; Ruiz-Canela M.; Guasch-Ferr\u00e9 M.; Corella D.; G\u00f3mez-Gracia E.; Fiol M.; Estruch R.; Ros E.; Lapetra J.; Fito M.; Aros F.; Serra-Majem L.; Lee C.H.; Clish C.B.; Liang L.; Salas-Salvad\u00f3 J.; Mart\u00ednez-Gonz\u00e1lez M.A.; Hu F.B.; Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the predimed trial (prevenci\u00f3n con dieta mediterr\u00e1nea). Circulation  2017,135(21),2028-2040","journal-title":"Circulation"},{"key":"ref=340","doi-asserted-by":"publisher","first-page":"13329","DOI":"10.14814\/phy2.13329","volume":"5","author":"Mathews A.T.","year":"2017","unstructured":"Mathews A.T.; Famodu O.A.; Olfert M.D.; Murray P.J.; Cuff C.F.; Downes M.T.; Haughey N.J.; Colby S.E.; Chantler P.D.; Olfert I.M.; McFadden J.W.; Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study. Physiol Rep  2017,5(13),13329","journal-title":"Physiol Rep"},{"key":"ref=341","doi-asserted-by":"publisher","first-page":"nzz039.P18-048-19","DOI":"10.1093\/cdn\/nzz039.P18-048-19","volume":"3","author":"Walker M.","year":"2019","unstructured":"Walker M.; Xanthakis V.; Ma J.; Quatromoni P.A.; Moore L.; Ramachandran V.; Jacques P.; A mediterranean style diet is favorably\nassociated with concentrations of circulating ceramides and\nceramide ratios in the framingham offspring cohort (P18-048-19). Curr Dev Nutr  2019,3,nzz039.P18-048-19","journal-title":"Curr Dev Nutr"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011570159X382929250719084728","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244361\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011570159X382929250719084728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:13:00Z","timestamp":1786511580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244361\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":341,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/011570159x382929250719084728","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}